{
  "conditions_to_closing": [
    {
      "section": "conditions_to_closing",
      "field_name": "mutual_conditions_list",
      "answer": [
        "The Company Stockholder Approval shall have been obtained.",
        "The Parent Stockholder Approval shall have been obtained.",
        "No injunction or other Order shall have been issued by any court or other Governmental Authority of competent jurisdiction and remain in effect that enjoins, prevents or prohibits the consummation of the Merger.",
        "The Registration Statement shall have been declared effective, no stop order suspending the effectiveness of the Registration Statement shall be in effect and no proceedings for such purpose shall be pending before the SEC.",
        "The shares of Parent Common Stock to be issued in the Parent Share Issuance and the New CVRs to be issued in the Merger shall have been approved for listing on the NYSE, subject to official notice of issuance.",
        "Any applicable waiting period under the HSR Act shall have expired or been terminated and any applicable waiting period or other Consent under each Foreign Antitrust Law set forth on Section 9.01(f) of the Company Disclosure Schedule relating to the transactions contemplated by this Agreement shall have expired, been terminated or obtained, as applicable."
      ],
      "summary": "The mutual conditions for closing include obtaining stockholder approvals, absence of legal prohibitions, effectiveness of the Registration Statement, listing approval on NYSE, and expiration or termination of waiting periods under antitrust laws.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The obligations of the Company, Parent and Merger Sub to consummate the Merger are subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver) of the following conditions: (a) the Company Stockholder Approval shall have been obtained; (b) the Parent Stockholder Approval shall have been obtained; (c) no injunction or other Order shall have been issued by any court or other Governmental Authority of competent jurisdiction and remain in effect that enjoins, prevents or prohibits the consummation of the Merger; (d) the Registration Statement shall have been declared effective, no stop order suspending the effectiveness of the Registration Statement shall be in effect and no proceedings for such purpose shall be pending before the SEC; (e) the shares of Parent Common Stock to be issued in the Parent Share Issuance and the New CVRs to be issued in the Merger shall have been approved for listing on the NYSE, subject to official notice of issuance; and (f) any applicable waiting period under the HSR Act shall have expired or been terminated and any applicable waiting period or other Consent under each Foreign Antitrust Law set forth on Section 9.01(f) of the Company Disclosure Schedule relating to the transactions contemplated by this Agreement shall have expired, been terminated or obtained, as applicable.",
      "reference_section": "ARTICLE Article IX CONDITIONS TO THE MERGER > Section 9.01 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_closing_conditions",
      "answer": [
        "The Company shall have performed, in all material respects, all of its obligations required to be performed at or prior to the Merger Effective Time.",
        "The representations and warranties of the Company in specified sections shall be true and correct in all material respects at the date of the Agreement and at the Closing, with certain exceptions for material adverse effects.",
        "Parent shall have received a certificate from an executive officer of the Company confirming the satisfaction of the conditions set forth in Section 9.02(a) and Section 9.02(b)."
      ],
      "summary": "The obligations of Parent and Merger Sub to consummate the Merger are subject to the Company's performance of obligations, accuracy of representations and warranties, and delivery of a certificate confirming these conditions.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The obligations of Parent and Merger Sub to consummate the Merger is subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver by Parent) of the following further conditions: (a) the Company shall have performed, in all material respects, all of its obligations hereunder required to be performed by it at or prior to the Merger Effective Time; (b) (i) the representations and warranties of the Company contained in Section 4.01 (other than the third sentence thereof), Section 4.02 (other than the last sentence of Section 4.02(b)), Section 4.04(a), Section 4.05(a), Section 4.05(b), Section 4.26, Section 4.27 and Section 4.28 shall be true and correct in all material respects at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing (or, if such representations and warranties are given as of another specific date, at and as of such date); (ii) the representations and warranties of the Company contained in Section 4.10(a)(ii) shall be true and correct in all respects at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing; and (iii) the other representations and warranties of the Company contained in this Agreement, disregarding all qualifications and exceptions contained therein relating to materiality or Company Material Adverse Effect, shall be true and correct at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing (or, if such representations and warranties are given as of another specific date, at and as of such date), except, in the case of this clause (iii) only, where the failure of such representations and warranties to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect (or, in the case of Section 4.16, a Parent Material Adverse Effect); and (c) Parent shall have received a certificate from an executive officer of the Company confirming the satisfaction of the conditions set forth in Section 9.02(a) and Section 9.02(b).",
      "reference_section": "ARTICLE IX CONDITIONS TO THE MERGER > Section 9.02 Conditions to the Obligations of Parent and Merger Sub"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "company_closing_conditions",
      "answer": [
        "Each of Parent and Merger Sub shall have performed, in all material respects, all of its obligations required to be performed at or prior to the Merger Effective Time.",
        "The representations and warranties of Parent in specified sections shall be true and correct in all material respects at the date of the Agreement and at the Closing.",
        "The representations and warranties of Parent in Section 5.10(a)(ii) shall be true and correct in all respects at the date of the Agreement and at the Closing.",
        "Other representations and warranties of Parent shall be true and correct, except where failure to be true and correct would not have a Parent Material Adverse Effect.",
        "The Company shall have received a certificate from an executive officer of Parent confirming the satisfaction of the conditions set forth in Section 9.03(a) and Section 9.03(b)."
      ],
      "summary": "The Company requires Parent and Merger Sub to perform obligations, ensure accuracy of representations and warranties, and provide a certificate confirming satisfaction of conditions for closing the merger.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The obligations of the Company to consummate the Merger are subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver by the Company) of the following further conditions: (a) each of Parent and Merger Sub shall have performed, in all material respects, all of its obligations hereunder required to be performed by it at or prior to the Merger Effective Time; (b) (i) the representations and warranties of Parent contained in Section 5.01 (other than the third and last sentences thereof), Section 5.02 (other than the last sentence of Section 5.02(b)), Section 5.04(a), Section 5.05, Section 5.23, Section 5.24 and Section 5.25 shall be true and correct in all material respects at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing (or, if such representations and warranties are given as of another specific date, at and as of such date); (ii) the representations and warranties of Parent contained in Section 5.10(a)(ii) shall be true and correct in all respects at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing; and (iii) the other representations and warranties of Parent contained in this Agreement, disregarding all qualifications and exceptions contained therein relating to materiality or Parent Material Adverse Effect, shall be true and correct at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing (or, if such representations and warranties are given as of another specific date, at and as of such date), except, in the case of this clause (iii) only, where the failure of such representations and warranties to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect; and (c) the Company shall have received a certificate from an executive officer of Parent confirming the satisfaction of the conditions set forth in Section 9.03(a) and Section 9.03(b).",
      "reference_section": "ARTICLE Article IX CONDITIONS TO THE MERGER > Section 9.03 Conditions to the Obligations of the Company"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_required",
      "answer": true,
      "summary": "",
      "confidence": 1.0,
      "reason": "The agreement explicitly states that the Company Stockholder Approval shall have been obtained as a condition to closing.",
      "clause_text": "The obligations of the Company, Parent and Merger Sub to consummate the Merger are subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver) of the following conditions: (a) the Company Stockholder Approval shall have been obtained;",
      "reference_section": "ARTICLE Article IX CONDITIONS TO THE MERGER > Section 9.01 Conditions to the Obligations of Each Party > (a)"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_threshold",
      "answer": "majority of the outstanding shares of Company Common Stock",
      "summary": "The affirmative vote of the holders of at least a majority of the outstanding shares of Company Common Stock is required for the Company Stockholder Approval.",
      "confidence": 1.0,
      "reason": "The document explicitly states the threshold for Company Stockholder Approval.",
      "clause_text": "The affirmative vote of the holders of at least a majority of the outstanding shares of Company Common Stock adopting this Agreement is the only vote of the holders of any of the Company's capital stock necessary in connection with the consummation of the Merger (the \"Company Stockholder Approval\").",
      "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.02 Corporate Authorization"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_shareholder_approval_required",
      "answer": true,
      "summary": "",
      "confidence": 1.0,
      "reason": "The agreement explicitly requires the Parent to obtain shareholder approval as a condition to closing.",
      "clause_text": "The affirmative vote of at least a majority of the votes cast by holders of outstanding shares of Parent Common Stock at a duly called and held meeting of Parent's stockholders at which a quorum is present approving the issuance of shares of Parent Common Stock in connection with the Merger (the 'Parent Share Issuance') is the only vote of the holders of any of Parent's capital stock necessary in connection with the consummation of the Merger (the 'Parent Stockholder Approval').",
      "reference_section": "ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.02 Corporate Authorization"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_shareholder_approval_threshold",
      "answer": "majority of the votes cast",
      "summary": "The affirmative vote of at least a majority of the votes cast by holders of outstanding shares of Parent Common Stock is required for the Parent Stockholder Approval.",
      "confidence": 0.95,
      "reason": "The document explicitly states the voting threshold required for Parent Stockholder Approval.",
      "clause_text": "The affirmative vote of at least a majority of the votes cast by holders of outstanding shares of Parent Common Stock at a duly called and held meeting of Parent's stockholders at which a quorum is present approving the issuance of shares of Parent Common Stock in connection with the Merger (the \"Parent Share Issuance\") is the only vote of the holders of any of Parent's capital stock necessary in connection with the consummation of the Merger (the \"Parent Stockholder Approval\").",
      "reference_section": "ARTICLE V – REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.02 Corporate Authorization"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "hsr_clearance_required",
      "answer": true,
      "summary": "",
      "confidence": 1.0,
      "reason": "The agreement explicitly includes the expiration or termination of the waiting period under the HSR Act as a condition to closing.",
      "clause_text": "The obligations of the Company, Parent and Merger Sub to consummate the Merger are subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver) of the following conditions: ... (f) any applicable waiting period under the HSR Act shall have expired or been terminated ...",
      "reference_section": "ARTICLE Article IX CONDITIONS TO THE MERGER > Section 9.01 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "other_customary_conditions",
      "answer": [
        "Company Stockholder Approval shall have been obtained",
        "Parent Stockholder Approval shall have been obtained",
        "No injunction or other Order shall have been issued by any court or other Governmental Authority of competent jurisdiction and remain in effect that enjoins, prevents or prohibits the consummation of the Merger",
        "The Registration Statement shall have been declared effective, no stop order suspending the effectiveness of the Registration Statement shall be in effect and no proceedings for such purpose shall be pending before the SEC",
        "The shares of Parent Common Stock to be issued in the Parent Share Issuance and the New CVRs to be issued in the Merger shall have been approved for listing on the NYSE, subject to official notice of issuance",
        "Any applicable waiting period under the HSR Act shall have expired or been terminated and any applicable waiting period or other Consent under each Foreign Antitrust Law set forth on Section 9.01(f) of the Company Disclosure Schedule relating to the transactions contemplated by this Agreement shall have expired, been terminated or obtained, as applicable"
      ],
      "summary": "The conditions to closing include obtaining stockholder approvals, effectiveness of the registration statement, absence of injunctions, listing approvals, and expiration or termination of waiting periods under antitrust laws.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The obligations of the Company, Parent and Merger Sub to consummate the Merger are subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver) of the following conditions: (a) the Company Stockholder Approval shall have been obtained; (b) the Parent Stockholder Approval shall have been obtained; (c) no injunction or other Order shall have been issued by any court or other Governmental Authority of competent jurisdiction and remain in effect that enjoins, prevents or prohibits the consummation of the Merger; (d) the Registration Statement shall have been declared effective, no stop order suspending the effectiveness of the Registration Statement shall be in effect and no proceedings for such purpose shall be pending before the SEC; (e) the shares of Parent Common Stock to be issued in the Parent Share Issuance and the New CVRs to be issued in the Merger shall have been approved for listing on the NYSE, subject to official notice of issuance; and (f) any applicable waiting period under the HSR Act shall have expired or been terminated and any applicable waiting period or other Consent under each Foreign Antitrust Law set forth on Section 9.01(f) of the Company Disclosure Schedule relating to the transactions contemplated by this Agreement shall have expired, been terminated or obtained, as applicable.",
      "reference_section": "ARTICLE Article IX CONDITIONS TO THE MERGER > Section 9.01 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_cash_threshold",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_maximum_net_debt",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_any_condition",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "tax_conditions_tax_opinion_required",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    }
  ],
  "material_adverse_effect": {
    "mae_carveout": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly exclude adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent or its Affiliates.",
        "clause_text": "Company Material Adverse Effect means any event, change, effect, development or occurrence that, individually or together with any other event, change, effect, development or occurrence, has had or would reasonably be expected to have a material adverse effect on the financial condition, business or results of operations of the Company and its Subsidiaries, taken as a whole; provided that no event, change, effect, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Company Material Adverse Effect or shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect: (i) any changes in general United States or global economic conditions, (ii) any changes in conditions generally affecting the industries in which the Company or any of its Subsidiaries operates, (iii) any decline, in and of itself, in the market price or trading volume of the Company Common Stock (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (iv) any changes in regulatory, legislative or political conditions or in securities, credit, financial, debt or other capital markets, in each case in the United States or any foreign jurisdiction, (v) any failure, in and of itself, by the Company or any of its Subsidiaries to meet any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (vi) the execution and delivery of this Agreement, the public announcement or the pendency of this Agreement or the pendency or consummation of the transactions contemplated by this Agreement (including the Merger), the taking of any action required or expressly contemplated by this Agreement or the identity of, or any facts or circumstances relating to Parent or any of its Subsidiaries, including the impact of any of the foregoing on the relationships, contractual or otherwise, of the Company or any of its Subsidiaries with Governmental Authorities, customers, suppliers, partners, officers, employees or other material business relations (it being understood and agreed that the foregoing shall not apply with respect to any representation or warranty that is expressly intended to address the consequences of the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby (including Section 4.04(c)) or with respect to the condition to Closing contained in Section 9.02(b), to the extent it relates to such representations and warranties), (vii) any adoption, implementation, promulgation, repeal, modification, amendment, authoritative interpretation, change or proposal of any Applicable Law of or by any Governmental Authority, (viii) any changes or prospective changes in GAAP (or authoritative interpretations thereof), (ix) any changes in geopolitical conditions, the outbreak or escalation of hostilities, any acts of war, sabotage, cyberattack or terrorism, or any escalation or worsening of any such acts of war, sabotage, cyberattack or terrorism threatened or underway as of the date of this Agreement, (x) the taking of any action at the written request of or with the written consent of Parent, (xi) any reduction in the credit rating of the Company or any of its Subsidiaries (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such reduction that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (xii) any epidemic, plague, pandemic or other outbreak of illness or public health event, hurricane, earthquake, flood or other natural disasters, acts of God or any change resulting from weather conditions, (xiii) any claims, actions, suits or proceedings arising from allegations of a breach of fiduciary duty or violation of Applicable Law relating to this Agreement or the transactions contemplated hereby (including the Merger), or (xiv) any regulatory or clinical changes, effects, developments or occurrences relating to any Company Pipeline Product (including (A) any suspension, rejection, refusal of, request to refile or any delay in obtaining or making any regulatory application or filing relating to any Company Pipeline Product, (B) any negative regulatory actions, requests, recommendations or decisions of any Governmental Authority relating to any Company Pipeline Product or any other regulatory or clinical development relating to any Company Pipeline Product, (C) any clinical studies, tests or results or announcements thereof with respect to any Company Pipeline Product, and (D) any delay, hold or termination of any clinical trial or any delay, hold or termination of any planned application for marketing approval with respect to any Company Pipeline Product) except in the case of each of clauses (i), (ii), (iv), (vii), (viii), (ix) or (xii), to the extent that any such event, change, effect, development or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such event, change, effect, development or occurrence has on other companies operating in the industries in which the Company and its Subsidiaries operate.",
        "reference_section": "ARTICLE I – DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_explanation",
        "answer": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "summary": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in general economic conditions shall not be deemed to constitute a Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any event, change, effect, development or occurrence that, individually or together with any other event, change, effect, development or occurrence, has had or would reasonably be expected to have a material adverse effect on the financial condition, business or results of operations of the Company and its Subsidiaries, taken as a whole; provided that no event, change, effect, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Company Material Adverse Effect or shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect: (i) any changes in general United States or global economic conditions...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes affecting the industries in which the Company operates from constituting a Material Adverse Effect.",
        "clause_text": "provided that no event, change, effect, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Company Material Adverse Effect or shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect: ... (ii) any changes in conditions generally affecting the industries in which the Company or any of its Subsidiaries operates, ...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_explanation",
        "answer": "any changes in conditions generally affecting the industries in which the Company or any of its Subsidiaries operates",
        "summary": "The clause excludes changes in industry conditions from being considered a Company Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that changes in industry conditions are not to be deemed a Company Material Adverse Effect.",
        "clause_text": "any changes in conditions generally affecting the industries in which the Company or any of its Subsidiaries operates",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in the market price or trading volume of the Company Common Stock from constituting a Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any event, change, effect, development or occurrence...; provided that no event, change, effect, development or occurrence to the extent resulting from, arising out of, or relating to... (iii) any decline, in and of itself, in the market price or trading volume of the Company Common Stock... shall be deemed to constitute a Company Material Adverse Effect...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_explanation",
        "answer": "any decline, in and of itself, in the market price or trading volume of the Company Common Stock",
        "summary": "The clause excludes any decline in the market price or trading volume of the Company Common Stock from being considered a Company Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that declines in stock price or trading volume are not considered a Company Material Adverse Effect.",
        "clause_text": "any decline, in and of itself, in the market price or trading volume of the Company Common Stock (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect)",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes reductions in credit ratings from constituting a Material Adverse Effect.",
        "clause_text": "any reduction in the credit rating of the Company or any of its Subsidiaries (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such reduction that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect)",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_explanation",
        "answer": "Changes in credit ratings are excluded from the definition of Company Material Adverse Effect.",
        "summary": "The agreement specifies that any reduction in the credit rating of the Company or its Subsidiaries shall not be deemed to constitute a Company Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that reductions in credit ratings are excluded from being considered a Company Material Adverse Effect.",
        "clause_text": "any reduction in the credit rating of the Company or any of its Subsidiaries (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such reduction that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect)",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in laws, regulations, GAAP, or accounting principles from constituting a Material Adverse Effect.",
        "clause_text": "provided that no event, change, effect, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Company Material Adverse Effect... (vii) any adoption, implementation, promulgation, repeal, modification, amendment, authoritative interpretation, change or proposal of any Applicable Law of or by any Governmental Authority, (viii) any changes or prospective changes in GAAP (or authoritative interpretations thereof)...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes acts of God, natural disasters, and weather events from constituting a Material Adverse Effect.",
        "clause_text": "any epidemic, plague, pandemic or other outbreak of illness or public health event, hurricane, earthquake, flood or other natural disasters, acts of God or any change resulting from weather conditions",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Parent Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_explanation",
        "answer": "Acts of God, natural disasters, and weather-related events are excluded from the definition of Material Adverse Effect.",
        "summary": "The definition of Material Adverse Effect excludes acts of God, natural disasters, and weather-related events, confirming these are not considered a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "any epidemic, plague, pandemic or other outbreak of illness or public health event, hurricane, earthquake, flood or other natural disasters, acts of God or any change resulting from weather conditions",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Parent Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes acts of war, terrorism, military conflict, or geopolitical instability from constituting a Material Adverse Effect.",
        "clause_text": "any changes in geopolitical conditions, the outbreak or escalation of hostilities, any acts of war, sabotage, cyberattack or terrorism, or any escalation or worsening of any such acts of war, sabotage, cyberattack or terrorism threatened or underway as of the date of this Agreement",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes pandemics, epidemics, or public health emergencies from constituting a Material Adverse Effect.",
        "clause_text": "Parent Material Adverse Effect means any event, change, effect, development or occurrence...; provided that no event, change, effect, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Parent Material Adverse Effect... (xii) any epidemic, plague, pandemic or other outbreak of illness or public health event...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Parent Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_explanation",
        "answer": "Pandemics, epidemics, or public health emergencies, including COVID-19, are excluded from the definition of a Material Adverse Effect.",
        "summary": "The definition of Company Material Adverse Effect explicitly excludes any epidemic, plague, pandemic, or other outbreak of illness or public health event from being considered a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Company Material Adverse Effect means any event, change, effect, development or occurrence that... has had or would reasonably be expected to have a material adverse effect...; provided that no event, change, effect, development or occurrence to the extent resulting from... (xii) any epidemic, plague, pandemic or other outbreak of illness or public health event... shall be deemed to constitute a Company Material Adverse Effect...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes effects resulting from the execution, delivery, or announcement of the merger agreement from constituting a Material Adverse Effect.",
        "clause_text": "the execution and delivery of this Agreement, the public announcement or the pendency of this Agreement or the pendency or consummation of the transactions contemplated by this Agreement (including the Merger), the taking of any action required or expressly contemplated by this Agreement or the identity of, or any facts or circumstances relating to Parent or any of its Subsidiaries, including the impact of any of the foregoing on the relationships, contractual or otherwise, of the Company or any of its Subsidiaries with Governmental Authorities, customers, suppliers, partners, officers, employees or other material business relations",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_explanation",
        "answer": "The effects resulting from the negotiation, execution, or announcement of the merger agreement are excluded from the MAE definition.",
        "summary": "The execution and delivery of the Agreement, the public announcement or the pendency of the Agreement, or the consummation of the transactions contemplated by the Agreement, including the Merger, are excluded from constituting a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly excludes effects resulting from the execution, announcement, or pendency of the Agreement from the MAE definition.",
        "clause_text": "the execution and delivery of this Agreement, the public announcement or the pendency of this Agreement or the pendency or consummation of the transactions contemplated by this Agreement (including the Merger),",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition excludes adverse effects caused by actions taken at the written request of or with the written consent of the Company.",
        "clause_text": "the taking of any action at the written request of or with the written consent of the Company",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Parent Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_explanation",
        "answer": "The definition of Company Material Adverse Effect excludes adverse effects resulting from actions taken at the written request or with the written consent of Parent.",
        "summary": "Adverse effects resulting from actions taken by the Company at the written request or with the written consent of Parent are excluded from the definition of Company Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that actions taken at the written request or with the written consent of Parent are excluded from being considered a Company Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any event, change, effect, development or occurrence... (x) the taking of any action at the written request of or with the written consent of Parent...",
        "reference_section": "ARTICLE I – DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes failures to meet projections, forecasts, estimates, or internal budgets from constituting a Material Adverse Effect.",
        "clause_text": "any failure, in and of itself, by the Company or any of its Subsidiaries to meet any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect)",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_explanation",
        "answer": "any failure, in and of itself, by the Company or any of its Subsidiaries to meet any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect)",
        "summary": "Failures to meet projections, forecasts, or estimates are excluded from the MAE definition unless contributing factors are not otherwise excluded.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "any failure, in and of itself, by the Company or any of its Subsidiaries to meet any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect)",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The clause includes carve-outs for 'cyberattack' and 'regulatory or clinical changes relating to any Company Pipeline Product,' which are not part of the standard exclusions.",
        "clause_text": "any acts of war, sabotage, cyberattack or terrorism, or any escalation or worsening of any such acts of war, sabotage, cyberattack or terrorism threatened or underway as of the date of this Agreement... any regulatory or clinical changes, effects, developments or occurrences relating to any Company Pipeline Product...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items",
        "answer": [
          {
            "label": "Regulatory or Clinical Changes Related to Pipeline Products",
            "excerpt": "any regulatory or clinical changes, effects, developments or occurrences relating to any Company Pipeline Product (including (A) any suspension, rejection, refusal of, request to refile or any delay in obtaining or making any regulatory application or filing relating to any Company Pipeline Product, (B) any negative regulatory actions, requests, recommendations or decisions of any Governmental Authority relating to any Company Pipeline Product or any other regulatory or clinical development relating to any Company Pipeline Product, (C) any clinical studies, tests or results or announcements thereof with respect to any Company Pipeline Product, and (D) any delay, hold or termination of any clinical trial or any delay, hold or termination of any planned application for marketing approval with respect to any Company Pipeline Product)"
          }
        ],
        "summary": "The MAE clause includes a carve-out for regulatory or clinical changes related to Company Pipeline Products, which is not part of the standard exclusions.",
        "confidence": 0.9,
        "reason": "The clause explicitly lists regulatory or clinical changes related to Company Pipeline Products as an exclusion, which is not covered by the standard exclusions.",
        "clause_text": "any regulatory or clinical changes, effects, developments or occurrences relating to any Company Pipeline Product (including (A) any suspension, rejection, refusal of, request to refile or any delay in obtaining or making any regulatory application or filing relating to any Company Pipeline Product, (B) any negative regulatory actions, requests, recommendations or decisions of any Governmental Authority relating to any Company Pipeline Product or any other regulatory or clinical development relating to any Company Pipeline Product, (C) any clinical studies, tests or results or announcements thereof with respect to any Company Pipeline Product, and (D) any delay, hold or termination of any clinical trial or any delay, hold or termination of any planned application for marketing approval with respect to any Company Pipeline Product)",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "standard_mae_carveouts_list",
        "answer": "Error: 'NoneType' object is not subscriptable",
        "confidence": 0.0,
        "reason": "Processing error",
        "clause_text": "",
        "reference_section": "",
        "categories_used": []
      }
    ],
    "mae_carveback": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE clause specifies that carve-outs are reintroduced if the Company is disproportionately affected compared to others in its industry.",
        "clause_text": "except in the case of each of clauses (i), (ii), (iv), (vii), (viii), (ix) or (xii), to the extent that any such event, change, effect, development or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such event, change, effect, development or occurrence has on other companies operating in the industries in which the Company and its Subsidiaries operate.",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_explanation",
        "answer": "except in the case of each of clauses (i), (ii), (iv), (vii), (viii), (ix) or (xii), to the extent that any such event, change, effect, development or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such event, change, effect, development or occurrence has on other companies operating in the industries in which the Company and its Subsidiaries operate.",
        "summary": "The MAE definition includes a carve-back stating that certain carve-outs do not apply if events disproportionately affect the Company relative to others in its industry.",
        "confidence": 0.95,
        "reason": "The clause explicitly mentions a disproportionate adverse effect on the Company relative to its industry peers.",
        "clause_text": "except in the case of each of clauses (i), (ii), (iv), (vii), (viii), (ix) or (xii), to the extent that any such event, change, effect, development or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such event, change, effect, development or occurrence has on other companies operating in the industries in which the Company and its Subsidiaries operate.",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The clause includes carve-back language specifying that certain events are excluded except to the extent they have a disproportionate adverse effect on the Company.",
        "clause_text": "except in the case of each of clauses (i), (ii), (iv), (vii), (viii), (ix) or (xii), to the extent that any such event, change, effect, development or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such event, change, effect, development or occurrence has on other companies operating in the industries in which the Company and its Subsidiaries operate.",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_explanation",
        "answer": [
          "Any decline in the market price or trading volume of the Company Common Stock is excluded from being considered a Company Material Adverse Effect, but the Parent can assert that any facts, events, developments, or occurrences contributing to such decline that are not otherwise excluded should be considered.",
          "Any failure by the Company or its Subsidiaries to meet projections or forecasts is excluded, but the Parent can assert that any contributing factors not otherwise excluded should be considered.",
          "Any reduction in the credit rating of the Company or its Subsidiaries is excluded, but the Parent can assert that any contributing factors not otherwise excluded should be considered.",
          "Events listed in clauses (i), (ii), (iv), (vii), (viii), (ix), or (xii) are excluded unless they have a disproportionate adverse effect on the Company and its Subsidiaries relative to other companies in the same industry."
        ],
        "summary": "The MAE clause includes carve-backs for certain excluded events, allowing them to be considered if they have a disproportionate impact or if underlying facts contribute to adverse effects.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows for certain excluded events to be reconsidered under specific conditions, such as disproportionate impact or contributing factors.",
        "clause_text": "it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition includes language indicating that underlying facts or occurrences contributing to certain excluded events may still be considered in determining a Material Adverse Effect.",
        "clause_text": "it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_explanation",
        "answer": "The facts or occurrences giving rise to an excluded event may still be taken into account in determining whether a Material Adverse Effect has occurred.",
        "summary": "The agreement allows for the consideration of facts or occurrences contributing to certain excluded events when determining a Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that facts, events, developments, or occurrences contributing to certain excluded events can be considered for a Material Adverse Effect.",
        "clause_text": "it being understood and agreed that the foregoing shall not preclude Parent from asserting that any facts, events, developments or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute a Company Material Adverse Effect or should be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      }
    ]
  },
  "non_solicitation": {
    "no_shop_clause": [
      {
        "section": "non_solicitation",
        "field_name": "no_shop_clause_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a 'No-Shop' clause as it explicitly restricts the Company from soliciting or facilitating any Company Acquisition Proposal.",
        "clause_text": "From the date of this Agreement until the earlier of the Merger Effective Time and the termination of this Agreement, except as otherwise set forth in this Section 6.02, the Company shall not, and shall cause its Subsidiaries and its and its Subsidiaries' directors and officers to not, and shall use its reasonable best efforts to cause its and its Subsidiaries' other Representatives to not, directly or indirectly, (i) solicit, initiate or take any action to knowingly facilitate or knowingly encourage (including by way of furnishing information) the submission of any Company Acquisition Proposal.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "no_shop_claus_explanation",
        "answer": "The Company agrees that from the date of this Agreement until the earlier of the Merger Effective Time and the termination of this Agreement, the Company shall not, and shall cause its Subsidiaries and its and its Subsidiaries' directors and officers to not, and shall use its reasonable best efforts to cause its and its Subsidiaries' other Representatives to not, directly or indirectly, solicit, initiate or take any action to knowingly facilitate or knowingly encourage (including by way of furnishing information) the submission of any Company Acquisition Proposal.",
        "summary": "The Company is restricted from soliciting, initiating, or facilitating any competing acquisition proposals until the merger is effective or the agreement is terminated.",
        "confidence": 1.0,
        "reason": "The clause explicitly prohibits the Company from engaging in activities that would facilitate competing acquisition proposals.",
        "clause_text": "The Company agrees that: (a) From the date of this Agreement until the earlier of the Merger Effective Time and the termination of this Agreement, except as otherwise set forth in this Section 6.02, the Company shall not, and shall cause its Subsidiaries and its and its Subsidiaries' directors and officers to not, and shall use its reasonable best efforts to cause its and its Subsidiaries' other Representatives to not, directly or indirectly, (i) solicit, initiate or take any action to knowingly facilitate or knowingly encourage (including by way of furnishing information) the submission of any Company Acquisition Proposal...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (a)"
      }
    ],
    "notice_of_competing_offer": [
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement requires the Company to notify Parent of any Company Acquisition Proposal or request for information related to such proposals.",
        "clause_text": "The Company shall notify Parent as promptly as practicable (but in no event later than forty eight (48) hours) after receipt by the Company (or any of its Representatives) of any Company Acquisition Proposal or any request for information relating to the Company or any of its Subsidiaries or for access to the business, properties, assets, books or records of the Company or any of its Subsidiaries by any Third Party that, to the knowledge of the Company, is reasonably likely to make or has made any Company Acquisition Proposal.",
        "reference_section": "ARTICLE VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_explanation",
        "answer": "The Company is required to notify the Buyer of a competing offer.",
        "summary": "The Company must notify Parent in writing within 48 hours of receiving any Company Acquisition Proposal, including the identity of the Third Party and material terms.",
        "confidence": 0.95,
        "reason": "The document explicitly states the obligation to notify Parent of any Company Acquisition Proposal.",
        "clause_text": "The Company shall notify Parent as promptly as practicable (but in no event later than forty eight (48) hours) after receipt by the Company (or any of its Representatives) of any Company Acquisition Proposal or any request for information relating to the Company or any of its Subsidiaries or for access to the business, properties, assets, books or records of the Company or any of its Subsidiaries by any Third Party that, to the knowledge of the Company, is reasonably likely to make or has made any Company Acquisition Proposal, which notice shall be provided in writing and shall identify the Third Party making, and the material terms and conditions of, any such Company Acquisition Proposal or request.",
        "reference_section": "ARTICLE VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (c)"
      }
    ],
    "ongoing_update": [
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement requires the Company to keep Parent reasonably informed of any material changes in the status and details of any Company Acquisition Proposal.",
        "clause_text": "The Company shall thereafter (x) keep Parent reasonably informed, on a reasonably current basis, of any material changes in the status and details of any such Company Acquisition Proposal or request and (y) as promptly as practicable (but in no event later than twenty four (24) hours after receipt) provide to Parent copies of all material correspondence and written materials sent or provided to the Company or any of its Subsidiaries that describes any terms or conditions of any Company Acquisition Proposal.",
        "reference_section": "ARTICLE VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_explanation",
        "answer": "The Company is obligated to provide ongoing updates to the Buyer regarding any changes in status or negotiations relating to a competing offer.",
        "summary": "The Company must notify Parent within 48 hours of receiving any Company Acquisition Proposal and keep Parent reasonably informed of material changes in status and details.",
        "confidence": 0.9,
        "reason": "The clause specifies the timing and frequency of updates the Company must provide to Parent regarding competing offers.",
        "clause_text": "The Company shall notify Parent as promptly as practicable (but in no event later than forty eight (48) hours) after receipt by the Company (or any of its Representatives) of any Company Acquisition Proposal... The Company shall thereafter (x) keep Parent reasonably informed, on a reasonably current basis, of any material changes in the status and details of any such Company Acquisition Proposal...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (c)"
      }
    ],
    "superior_proposal_engagement": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement allows the target company to engage in discussions or negotiations with a third party that submits a Superior Proposal, subject to certain conditions.",
        "clause_text": "the Board of Directors of the Company, directly or indirectly through its Representatives, may (x) contact the Third Party that has made such Company Acquisition Proposal in order to ascertain facts or clarify terms... and (y) subject to compliance with this Section 6.02(b), Section 6.02(c) and Section 6.02(e), (i) engage in negotiations or discussions with any Third Party that... has made after the date of this Agreement a Company Superior Proposal...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_explanation",
        "answer": "The Company is authorized to engage with third parties if a Superior Proposal is received, provided that the Board of Directors determines in good faith that the failure to do so would be inconsistent with its fiduciary duties.",
        "summary": "The Company may engage in negotiations or discussions with a third party that has made a Superior Proposal if the Board of Directors determines in good faith that not doing so would be inconsistent with its fiduciary duties.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows engagement with third parties upon receiving a Superior Proposal, contingent on fiduciary duty considerations.",
        "clause_text": "The Board of Directors of the Company, directly or indirectly through its Representatives, may (x) contact the Third Party that has made such Company Acquisition Proposal in order to ascertain facts or clarify terms for the sole purpose of the Board of Directors of the Company informing itself about such Company Acquisition Proposal and such Third Party and (y) subject to compliance with this Section 6.02(b), Section 6.02(c) and Section 6.02(e), (i) engage in negotiations or discussions with any Third Party that, subject to the Company's compliance with Section 6.02(a), has made after the date of this Agreement a Company Superior Proposal or an unsolicited bona fide written Company Acquisition Proposal that the Board of Directors of the Company determines in good faith, after consultation with its financial advisor and outside legal counsel, is or could reasonably be expected to lead to a Company Superior Proposal, (ii) furnish to such Third Party and its Representatives and financing sources nonpublic information relating to the Company or any of its Subsidiaries pursuant to a confidentiality agreement with confidentiality and use provisions no less favorable and other provisions no less favorable in the aggregate, in each case, to the Company than those contained in the Confidentiality Agreement, a copy of which shall be provided, promptly after its execution, to Parent for informational purposes; provided that all such non-public information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available to Parent, as the case may be, substantially concurrently with the time it is provided or made available to such Third Party, and (iii) following receipt of a Company Superior Proposal after the date of this Agreement, (A) make a Company Adverse Recommendation Change and/or (B) terminate this Agreement in accordance with Section 10.01(d)(iii) to enter into a definitive agreement providing for such Company Superior Proposal, but in the case of this clause (iii) only if the Board of Directors of the Company determines in good faith, after consultation with the Company's outside legal counsel and financial advisor, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (b)"
      }
    ],
    "match_right": [
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement grants the buyer a right to match an initial Superior Proposal received by the target, as evidenced by the language allowing the Company to notify Parent and negotiate in good faith regarding any proposal by Parent to amend the terms of the Agreement in response to a Company Superior Proposal.",
        "clause_text": "The Company first notifies Parent, in writing at least four (4) Business Days before taking such action, that the Company intends to take such action... if requested by Parent, during such four (4) Business Day period, the Company and its Representatives have discussed and negotiated in good faith with Parent (to the extent that Parent desires to so negotiate) regarding any proposal by Parent to amend the terms of this Agreement in response to such Company Superior Proposal.",
        "reference_section": "ARTICLE VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_explanation",
        "answer": "The Company must notify Parent in writing at least four (4) Business Days before taking action on a Company Superior Proposal, allowing Parent to negotiate in good faith to amend the terms of the Agreement.",
        "summary": "The Company must notify Parent in writing at least four (4) Business Days before taking action on a Company Superior Proposal, allowing Parent to negotiate in good faith to amend the terms of the Agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly outlines the requirement for a four (4) Business Day notice period and negotiation opportunity for Parent.",
        "clause_text": "Without limiting or affecting Section 6.02(a), Section 6.02(b) or Section 6.02(c), the Board of Directors of the Company shall not make a Company Adverse Recommendation Change involving or relating to a Company Superior Proposal or terminate this Agreement to enter into a definitive agreement with respect to a Company Superior Proposal unless (i) the Company first notifies Parent, in writing at least four (4) Business Days before taking such action, that the Company intends to take such action...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly provides a renewed right to match for amended proposals, as indicated by the requirement for a new notice period in the event of any amendment to the financial terms or other material terms of a Company Superior Proposal.",
        "clause_text": "it being understood and agreed that in the event of any amendment to the financial terms or other material terms of any such Company Superior Proposal, a new written notification from the Company consistent with that described in clause (i) of this Section 6.02(e) shall be required, and a new notice period under clause (i) of this Section 6.02(e) shall commence, during which notice period the Company shall be required to comply with the requirements of this Section 6.02(e) anew, except that such new notice period shall be for two (2) Business Days (as opposed to four (4) Business Days).",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_explanation",
        "answer": "The agreement permits the Buyer to respond to a modified or revised Superior Proposal by providing a new notice and a new negotiation period of two (2) Business Days.",
        "summary": "The agreement allows the Buyer to respond to a modified or revised Superior Proposal with a new notice and a two (2) Business Day negotiation period.",
        "confidence": 0.9,
        "reason": "The clause specifies that in the event of any amendment to the financial terms or other material terms of a Company Superior Proposal, a new notice period of two (2) Business Days shall commence.",
        "clause_text": "it being understood and agreed that in the event of any amendment to the financial terms or other material terms of any such Company Superior Proposal, a new written notification from the Company consistent with that described in clause (i) of this Section 6.02(e) shall be required, and a new notice period under clause (i) of this Section 6.02(e) shall commence, during which notice period the Company shall be required to comply with the requirements of this Section 6.02(e) anew, except that such new notice period shall be for two (2) Business Days (as opposed to four (4) Business Days)).",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (e)"
      }
    ],
    "adverse_recommendation_change": [
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The board of directors is permitted to make a Company Adverse Recommendation Change following receipt of a Company Superior Proposal, provided certain conditions are met.",
        "clause_text": "following receipt of a Company Superior Proposal after the date of this Agreement, (A) make a Company Adverse Recommendation Change and/or (B) terminate this Agreement in accordance with Section 10.01(d)(iii) to enter into a definitive agreement providing for such Company Superior Proposal, but in the case of this clause (iii) only if the Board of Directors of the Company determines in good faith, after consultation with the Company's outside legal counsel and financial advisor, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_explanation",
        "answer": "The Company Board is permitted to change its recommendation in response to a Superior Proposal.",
        "summary": "The Company Board may make an adverse recommendation change following receipt of a Company Superior Proposal if it determines in good faith, after consultation with legal and financial advisors, that not doing so would be inconsistent with its fiduciary duties.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "following receipt of a Company Superior Proposal after the date of this Agreement, (A) make a Company Adverse Recommendation Change and/or (B) terminate this Agreement in accordance with Section 10.01(d)(iii) to enter into a definitive agreement providing for such Company Superior Proposal, but in the case of this clause (iii) only if the Board of Directors of the Company determines in good faith, after consultation with the Company's outside legal counsel and financial advisor, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly allows the Company Board to change its recommendation due to a Company Intervening Event.",
        "clause_text": "Notwithstanding anything in this Agreement to the contrary, at any time prior to the Company Approval Time (and in no event after the Company Approval Time), the Board of Directors of the Company may effect a Company Adverse Recommendation Change involving or relating to a Company Intervening Event if the Board of Directors of the Company determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_explanation",
        "answer": "The Company Board may change its recommendation due to an Intervening Event if it determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law.",
        "summary": "The Company Board may change its recommendation due to an Intervening Event if it determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Notwithstanding anything in this Agreement to the contrary, at any time prior to the Company Approval Time (and in no event after the Company Approval Time), the Board of Directors of the Company may effect a Company Adverse Recommendation Change involving or relating to a Company Intervening Event if the Board of Directors of the Company determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_timing",
        "answer": "The Company must notify Parent in writing at least four (4) Business Days before making a Company Adverse Recommendation Change involving a Company Superior Proposal, and if requested, negotiate in good faith with Parent during this period.",
        "summary": "The Company must notify Parent in writing at least four (4) Business Days before making a Company Adverse Recommendation Change involving a Company Superior Proposal, and if requested, negotiate in good faith with Parent during this period.",
        "confidence": 0.9,
        "reason": "The document specifies a four (4) Business Day notice period and negotiation requirement before a Company Adverse Recommendation Change.",
        "clause_text": "Without limiting or affecting Section 6.02(a), Section 6.02(b) or Section 6.02(c), the Board of Directors of the Company shall not make a Company Adverse Recommendation Change involving or relating to a Company Superior Proposal or terminate this Agreement to enter into a definitive agreement with respect to a Company Superior Proposal unless (i) the Company first notifies Parent, in writing at least four (4) Business Days before taking such action, that the Company intends to take such action...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (e)"
      }
    ],
    "go_shop": [
      {
        "section": "non_solicitation",
        "field_name": "go_shop_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement prohibits the Company from soliciting or facilitating acquisition proposals, indicating no go-shop provision.",
        "clause_text": "The Company shall not, and shall cause its Subsidiaries and its and its Subsidiaries' directors and officers to not, and shall use its reasonable best efforts to cause its and its Subsidiaries' other Representatives to not, directly or indirectly, (i) solicit, initiate or take any action to knowingly facilitate or knowingly encourage (including by way of furnishing information) the submission of any Company Acquisition Proposal.",
        "reference_section": "ARTICLE VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "go_shop_explanation",
        "answer": "The Company is permitted to engage in negotiations or discussions with any Third Party that has made a Company Superior Proposal or an unsolicited bona fide written Company Acquisition Proposal that could reasonably be expected to lead to a Company Superior Proposal, prior to the receipt of the Company Stockholder Approval.",
        "summary": "The Company may engage with third parties for superior proposals before stockholder approval.",
        "confidence": 0.9,
        "reason": "The clause allows the Company to engage with third parties for superior proposals before stockholder approval.",
        "clause_text": "Notwithstanding the foregoing, if at any time prior to the receipt of the Company Stockholder Approval (the \"Company Approval Time\") (and in no event after the Company Approval Time), the Board of Directors of the Company receives a bona fide written Company Acquisition Proposal made after the date hereof which has not resulted from a violation of this Section 6.02, the Board of Directors of the Company, directly or indirectly through its Representatives, may (x) contact the Third Party that has made such Company Acquisition Proposal in order to ascertain facts or clarify terms for the sole purpose of the Board of Directors of the Company informing itself about such Company Acquisition Proposal and such Third Party and (y) subject to compliance with this Section 6.02(b), Section 6.02(c) and Section 6.02(e), (i) engage in negotiations or discussions with any Third Party that, subject to the Company's compliance with Section 6.02(a), has made after the date of this Agreement a Company Superior Proposal or an unsolicited bona fide written Company Acquisition Proposal that the Board of Directors of the Company determines in good faith, after consultation with its financial advisor and outside legal counsel, is or could reasonably be expected to lead to a Company Superior Proposal.",
        "reference_section": "ARTICLE VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (b)"
      }
    ],
    "buyer_diligence_access": [
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement grants the buyer the right to receive any diligence materials shared with a third party, as indicated by the language 'all such non-public information...is provided or made available to Parent...substantially concurrently with the time it is provided or made available to such Third Party.'",
        "clause_text": "provided that all such non-public information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available to Parent, as the case may be, substantially concurrently with the time it is provided or made available to such Third Party",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_explanation",
        "answer": "The Company must share any non-public information provided to a third party with Parent.",
        "summary": "The Company is obligated to provide Parent with any non-public information shared with a third party in connection with a Company Acquisition Proposal.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that non-public information provided to a third party must be made available to Parent.",
        "clause_text": "provided that all such non-public information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available to Parent, as the case may be, substantially concurrently with the time it is provided or made available to such Third Party",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (b)"
      }
    ],
    "recommendation_change_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement imposes restrictions on the board of directors regarding communication of a change in recommendation, requiring prior notice to the Parent and a waiting period before taking action.",
        "clause_text": "The Board of Directors of the Company shall not take any of the actions referred to in clauses (i) through (iii) of Section 6.02(b) unless the Company shall have first delivered to Parent written notice advising Parent that the Company intends to take such action.",
        "reference_section": "ARTICLE VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_explanation",
        "answer": "The agreement imposes procedural and timing-based restrictions on how the Company may change its recommendation.",
        "summary": "The Company must provide written notice to Parent at least four business days before making a recommendation change, engage in good faith negotiations if requested, and reassess the proposal after the notice period.",
        "confidence": 0.9,
        "reason": "The agreement specifies a notice period and negotiation requirements before a recommendation change.",
        "clause_text": "Without limiting or affecting Section 6.02(a), Section 6.02(b) or Section 6.02(c), the Board of Directors of the Company shall not make a Company Adverse Recommendation Change involving or relating to a Company Superior Proposal or terminate this Agreement to enter into a definitive agreement with respect to a Company Superior Proposal unless (i) the Company first notifies Parent, in writing at least four (4) Business Days before taking such action...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (e)"
      }
    ]
  },
  "best_efforts": {
    "regulatory_efforts": [
      {
        "section": "best_efforts",
        "field_name": "effort_standard",
        "answer": "Reasonable Best Efforts",
        "summary": "The parties are required to use their reasonable best efforts to take all necessary actions to consummate the merger and obtain required consents, including contesting legal actions and complying with antitrust laws.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the use of 'reasonable best efforts' to achieve regulatory approvals and consummate the merger.",
        "clause_text": "Subject to the terms and conditions of this Agreement, including Section 8.02(b) and Section 8.02(c), each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as practicable...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "effort_scope",
        "answer": "RBE for HSR and Foreign Antitrust Law filings",
        "summary": "The effort scope includes using reasonable best efforts to comply with the HSR Act and any Foreign Antitrust Law in relation to the merger.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the HSR Act and Foreign Antitrust Law as part of the regulatory efforts required.",
        "clause_text": "nothing in this Agreement will obligate or require Parent, Merger Sub or any of their respective Subsidiaries to take or cause to be taken any action (or refrain or cause to refrain from taking any action) or agree or cause to agree to any term, condition or limitation (including, in each case, any of the actions or items referred to in the last sentence of Section 8.02(a)) as a condition to, or in connection with, (i) the expiration or termination of any applicable waiting period relating to the Merger under the HSR Act, (ii) any Foreign Antitrust Law or (iii) obtaining any other Consent from a Governmental Authority or otherwise...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (b)"
      }
    ],
    "regulatory_fillings_hsr": [
      {
        "section": "best_efforts",
        "field_name": "hsr_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that compliance with the HSR Act is necessary for the consummation of the merger.",
        "clause_text": "The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby require no action by or in respect of, Consents of, or Filings with, any Governmental Authority other than... (b) compliance with any applicable requirements of the HSR Act...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.03 Governmental Authorization"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_filing_deadline_days",
        "answer": "10",
        "summary": "The parties are required to make their HSR filing no later than ten (10) Business Days following the date of the Agreement.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline of ten (10) Business Days for making the HSR filing.",
        "clause_text": "not later than ten (10) Business Days following the date of this Agreement (unless the parties otherwise agree to another time period), the Company and Parent each making an appropriate Filing of a notification and report form pursuant to the HSR Act",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (d) > (i)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_notes",
        "answer": "Must file within 10 business days of signing; filing required under HSR Act as a condition to closing.",
        "summary": "Must file within 10 business days of signing; filing required under HSR Act as a condition to closing.",
        "confidence": 0.9,
        "reason": "The document specifies a filing deadline and the necessity of compliance with the HSR Act.",
        "clause_text": "not later than ten (10) Business Days following the date of this Agreement (unless the parties otherwise agree to another time period), the Company and Parent each making an appropriate Filing of a notification and report form pursuant to the HSR Act with the Federal Trade Commission and the Antitrust Division of the United States Department of Justice with respect to the Merger and the other transactions contemplated hereby and requesting early termination of the waiting period under the HSR Act;",
        "reference_section": "ARTICLE VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (d) > (i)"
      }
    ],
    "regulatory_fillings_cfius": [
      {
        "section": "best_efforts",
        "field_name": "cfius_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of a CFIUS filing or clearance requirement in the provided sections.",
        "clause_text": "The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby require no action by or in respect of, Consents of, or Filings with, any Governmental Authority other than (a) the filing of the Certificate of Merger with the Delaware Secretary of State and appropriate documents with the relevant authorities of other states in which the Company is qualified to do business, (b) compliance with any applicable requirements of the HSR Act, (c) compliance with and Filings under any applicable Antitrust Laws of any non-U.S. jurisdictions (collectively, \"Foreign Antitrust Laws\"), (d) compliance with any applicable requirements of the 1933 Act, the 1934 Act and any other applicable U.S. state or federal securities laws or pursuant to the rules of the NASDAQ Global Select Market and NASDAQ Global Market (collectively, \"Nasdaq\"), and (e) any other actions, Consents or Filings the absence of which has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.03 Governmental Authorization"
      },
      {
        "section": "best_efforts",
        "field_name": "cfius_filing_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfius_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_fillings_foreign": [
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_notes",
        "answer": "Foreign filings may be required under applicable non-U.S. laws",
        "summary": "Foreign filings may be required under applicable non-U.S. laws as the agreement includes compliance with and filings under any applicable Antitrust Laws of any non-U.S. jurisdictions.",
        "confidence": 0.9,
        "reason": "The agreement explicitly mentions compliance with and filings under any applicable Antitrust Laws of non-U.S. jurisdictions.",
        "clause_text": "The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby require no action by or in respect of, Consents of, or Filings with, any Governmental Authority other than ... (c) compliance with and Filings under any applicable Antitrust Laws of any non-U.S. jurisdictions (collectively, 'Foreign Antitrust Laws')...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.03 Governmental Authorization"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement requires compliance with and filings under applicable Antitrust Laws of non-U.S. jurisdictions, indicating foreign filings are required.",
        "clause_text": "The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby require no action by or in respect of, Consents of, or Filings with, any Governmental Authority other than ... (c) compliance with and Filings under any applicable Antitrust Laws of any non-U.S. jurisdictions (collectively, 'Foreign Antitrust Laws')...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.03 Governmental Authorization"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "divestiture_commitments": [
      {
        "section": "best_efforts",
        "field_name": "divestiture_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement permits divestitures, hold separate arrangements, and other commitments to secure regulatory approval.",
        "clause_text": "The parties understand and agree that, subject to Section 8.02(b) and Section 8.02(g), Parent's obligation to use its reasonable best efforts set forth in this Section 8.02(a) includes taking and agreeing to take all actions and doing or agreeing to do all things necessary, proper or advisable under Applicable Law (including divestitures, hold separate arrangements, the termination, assignment, novation or modification of Contracts (or portions thereof) or other business relationships, the acceptance of restrictions on business operations and the entry into other commitments and limitations) to satisfy the conditions set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to any Antitrust Law) and to consummate the Merger and the other transactions contemplated hereby.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_notes",
        "answer": "Parent is not required to take any action that would have a material adverse effect on the financial condition, business, or results of operations of the Company, Parent, and their respective Subsidiaries after the Merger.",
        "summary": "Parent is not obligated to take any action or agree to any term that would have a material adverse effect on the financial condition, business, or results of operations of the Company, Parent, and their respective Subsidiaries after the Merger.",
        "confidence": 0.9,
        "reason": "The clause explicitly limits Parent's obligations to actions that do not have a material adverse effect.",
        "clause_text": "Notwithstanding Section 8.02(a) or anything else in this Agreement to the contrary, nothing in this Agreement will obligate or require Parent, Merger Sub or any of their respective Subsidiaries to take or cause to be taken any action (or refrain or cause to refrain from taking any action) or agree or cause to agree to any term, condition or limitation... if such action (or refraining from such action), term, condition or limitation would have or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the financial condition, business or results of operations of the Company, Parent and their respective Subsidiaries, taken as a whole, after giving effect to the Merger.",
        "reference_section": "ARTICLE VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (b)"
      }
    ],
    "litigation_commitments": [
      {
        "section": "best_efforts",
        "field_name": "litigation_requirement_status",
        "answer": "Explicit Requirement to Litigate",
        "summary": "The agreement requires the parties to use reasonable best efforts to contest any legal actions or orders that seek to prevent the merger, including through litigation.",
        "confidence": 0.9,
        "reason": "The language in Section 8.02(a)(ii) explicitly includes litigation as part of the efforts to contest actions or orders preventing the merger.",
        "clause_text": "each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as practicable, including... using reasonable best efforts to contest (which includes by litigation) any (A) action, suit, investigation or proceeding...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts"
      },
      {
        "section": "best_efforts",
        "field_name": "litigation_clause_scope",
        "answer": "Litigate through appeals unless it would have a material adverse effect on the financial condition, business, or results of operations of the Company, Parent, and their respective Subsidiaries, taken as a whole, after giving effect to the Merger.",
        "summary": "The Buyer is obligated to litigate through appeals unless such action would have a material adverse effect on the financial condition, business, or results of operations of the Company, Parent, and their Subsidiaries.",
        "confidence": 0.9,
        "reason": "The obligation to litigate is limited by the potential for a material adverse effect on the financial condition, business, or results of operations.",
        "clause_text": "nothing in this Agreement will obligate or require Parent, Merger Sub or any of their respective Subsidiaries to take or cause to be taken any action (or refrain or cause to refrain from taking any action) or agree or cause to agree to any term, condition or limitation...if such action (or refraining from such action), term, condition or limitation would have or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the financial condition, business or results of operations of the Company, Parent and their respective Subsidiaries, taken as a whole, after giving effect to the Merger.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "required_to_litigate_notes",
        "answer": "Buyer must litigate regulatory challenges unless conditions to closing are impossible.",
        "summary": "Buyer must litigate regulatory challenges unless conditions to closing are impossible.",
        "confidence": 0.9,
        "reason": "The clause specifies that litigation is required to contest actions or orders that prevent the merger, but also includes limitations if such actions would have a material adverse effect.",
        "clause_text": "The parties understand and agree that, subject to Section 8.02(b) and Section 8.02(g), Parent's obligation to use its reasonable best efforts set forth in this Section 8.02(a) includes taking and agreeing to take all actions and doing or agreeing to do all things necessary, proper or advisable under Applicable Law (including divestitures, hold separate arrangements, the termination, assignment, novation or modification of Contracts (or portions thereof) or other business relationships, the acceptance of restrictions on business operations and the entry into other commitments and limitations) to satisfy the conditions set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to any Antitrust Law) and to consummate the Merger and the other transactions contemplated hereby.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      }
    ],
    "withdrawal_and_timing_controls_withdrawal": [
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type",
        "answer": "buyer_only",
        "summary": "The agreement specifies that the Parent has the right to direct, devise, and implement the strategy for obtaining necessary approvals and to control the defense and settlement of any litigation related to Antitrust Law.",
        "confidence": 0.9,
        "reason": "The agreement explicitly grants the Parent control over the strategy and defense related to regulatory filings and Antitrust Law.",
        "clause_text": "Parent shall have the right to (i) direct, devise and implement the strategy for obtaining any necessary approval of, for responding to any request from, inquiry or investigation by (including directing the timing, nature and substance of all such responses), and shall have the right to lead all meetings and communications (including any negotiations) with, any Governmental Authority that has authority to enforce any Antitrust Law and (ii) without limiting the generality of clause (i) of this Section 8.02(c) or the obligations of the Company under this Section 8.02, control the defense and settlement of any litigation, action, suit, investigation or proceeding brought by or before any Governmental Authority that has authority to enforce any Antitrust Law.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (c)"
      },
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "withdrawal_and_timing_controls_timing": [
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit language in the provided excerpts stating that neither party shall enter into any timing or similar agreement under the HSR Act without the other party’s prior written consent.",
        "clause_text": "The excerpts do not contain any mention of a restriction on entering timing agreements under the HSR Act without prior written consent.",
        "reference_section": "Not applicable as the specific clause is not present in the provided excerpts."
      },
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction_notes",
        "answer": "The agreement outlines timing restrictions related to obtaining necessary consents and complying with antitrust laws, including the HSR Act, and specifies that Parent's consent is required for certain actions.",
        "summary": "The agreement outlines timing restrictions related to obtaining necessary consents and complying with antitrust laws, including the HSR Act, and specifies that Parent's consent is required for certain actions.",
        "confidence": 0.9,
        "reason": "The agreement specifies that Parent's consent is required for certain actions related to timing and compliance with antitrust laws.",
        "clause_text": "Notwithstanding Section 8.02(a) or anything else in this Agreement to the contrary, nothing in this Agreement will obligate or require Parent, Merger Sub or any of their respective Subsidiaries to take or cause to be taken any action (or refrain or cause to refrain from taking any action) or agree or cause to agree to any term, condition or limitation (including, in each case, any of the actions or items referred to in the last sentence of Section 8.02(a)) as a condition to, or in connection with, (i) the expiration or termination of any applicable waiting period relating to the Merger under the HSR Act, (ii) any Foreign Antitrust Law or (iii) obtaining any other Consent from a Governmental Authority or otherwise, in each case if such action (or refraining from such action), term, condition or limitation would have or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the financial condition, business or results of operations of the Company, Parent and their respective Subsidiaries, taken as a whole, after giving effect to the Merger.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (b)"
      }
    ],
    "remedy_actions_other": [
      {
        "section": "best_efforts",
        "field_name": "remedy_definitions_provided",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement provides detailed obligations and actions related to regulatory best efforts, including contesting legal actions and obtaining necessary consents.",
        "clause_text": "The parties understand and agree that, subject to Section 8.02(b) and Section 8.02(g), Parent's obligation to use its reasonable best efforts set forth in this Section 8.02(a) includes taking and agreeing to take all actions and doing or agreeing to do all things necessary, proper or advisable under Applicable Law (including divestitures, hold separate arrangements, the termination, assignment, novation or modification of Contracts (or portions thereof) or other business relationships, the acceptance of restrictions on business operations and the entry into other commitments and limitations) to satisfy the conditions set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to any Antitrust Law) and to consummate the Merger and the other transactions contemplated hereby.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "transaction_interference": [
      {
        "section": "best_efforts",
        "field_name": "restriction_on_other_transactions",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement restricts both parties from soliciting or pursuing alternative transactions that could interfere with regulatory approvals.",
        "clause_text": "From the date of this Agreement until the earlier of the Merger Effective Time and the termination of this Agreement, except as otherwise set forth in this Section 6.02, the Company shall not, and shall cause its Subsidiaries and its and its Subsidiaries' directors and officers to not, and shall use its reasonable best efforts to cause its and its Subsidiaries' other Representatives to not, directly or indirectly, (i) solicit, initiate or take any action to knowingly facilitate or knowingly encourage (including by way of furnishing information) the submission of any Company Acquisition Proposal...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company"
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "second_request_certification": [
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_deadline_specified",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no language specifying a concrete deadline for certifying compliance with the Second Request under the HSR Act.",
        "clause_text": "The provided excerpts do not contain any specific number of days or exact date tied to Second Request compliance.",
        "reference_section": "Not applicable as no specific section provides the required information."
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_certification_timeline_notes",
        "answer": "as promptly as practicable",
        "summary": "The agreement requires the parties to use reasonable best efforts to make all necessary filings with governmental authorities, including those related to the HSR Act, as promptly as practicable.",
        "confidence": 0.9,
        "reason": "The language 'as promptly as practicable' in the context of regulatory filings implies a timeline for certifying compliance with a Second Request under the HSR Act.",
        "clause_text": "each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as practicable, including (i) (A) preparing and filing as promptly as practicable with any Governmental Authority or other Third Party all documentation to effect all Filings as are necessary, proper or advisable to consummate the Merger and the other transactions contemplated hereby...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_responsibility_party",
        "answer": "Both",
        "summary": "Both the Company and Parent are responsible for making filings and complying with the HSR Act, as they are required to use reasonable best efforts to prepare and file necessary documentation and cooperate with each other.",
        "confidence": 0.9,
        "reason": "The agreement specifies that both parties must use reasonable best efforts to comply with the HSR Act, implying joint responsibility.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each of the Company and Parent shall, and each shall cause its Subsidiaries to, as promptly as practicable following the date of this Agreement, make all Filings with all Governmental Authorities that are necessary, proper or advisable under this Agreement or Applicable Law to consummate and make effective the Merger and the other transactions contemplated hereby, including: (i) not later than ten (10) Business Days following the date of this Agreement (unless the parties otherwise agree to another time period), the Company and Parent each making an appropriate Filing of a notification and report form pursuant to the HSR Act...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (d)"
      }
    ],
    "ftc_warning_letter_handling": [
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not mention FTC warning letters or similar preliminary regulatory communications.",
        "clause_text": "The document sections provided focus on regulatory matters related to the FDA and other regulatory agencies but do not mention FTC warning letters or similar communications.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.15 Regulatory Matters"
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_notes",
        "answer": "Not addressed",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_effect_on_closing_condition",
        "answer": "Silent",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "other_timing_controls": [
      {
        "section": "best_efforts",
        "field_name": "other_timing_controls_deadlines_specified",
        "answer": [
          "Company Stockholder Meeting to occur within 40 days of the Company Record Date, subject to an extension of up to 15 additional Business Days.",
          "Parent Stockholder Meeting to occur within 40 days of the Company Record Date, subject to an extension of up to 15 additional Business Days.",
          "Company may not postpone the Company Stockholder Meeting more than three times, each postponement not exceeding 10 Business Days without Parent's consent.",
          "Parent may not postpone the Parent Stockholder Meeting more than three times, each postponement not exceeding 10 Business Days without Company's consent."
        ],
        "summary": "The agreement specifies deadlines for the Company and Parent Stockholder Meetings to occur within 40 days of the Company Record Date, with possible extensions. It also limits postponements to three times, each not exceeding 10 Business Days without consent.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Promptly following the effectiveness of the Registration Statement (and, in the case of clause (iii), within forty (40) days of the Company Record Date, subject to an extension of up to fifteen (15) additional Business Days as contemplated by the last sentence of this Section 8.04(b)), Parent shall, in consultation with the Company, in accordance with Applicable Law and the Parent Organizational Documents, (i) establish a record date (which date shall be the same as the Company Record Date) for, duly call and give notice of a meeting of the stockholders of Parent entitled to vote on the Parent Share Issuance (the \"Parent Stockholder Meeting\") at which meeting Parent shall seek the Parent Stockholder Approval (and will use reasonable best efforts to conduct \"broker searches\" in a manner to enable the such record date to be held on such date), (ii) cause the Joint Proxy Statement/Prospectus (and all other proxy materials for the Parent Stockholder Meeting) to be mailed to its stockholders and (iii) duly convene and hold the Parent Stockholder Meeting.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings"
      }
    ],
    "novel_or_unstructured_regulatory_clauses": [
      {
        "section": "best_efforts",
        "field_name": "novel_or_unstructured_regulatory_clauses_items",
        "answer": [
          {
            "summary": "Parent has the right to direct and control the strategy for obtaining necessary antitrust approvals, including leading negotiations with relevant authorities.",
            "section_or_clause_reference": "ARTICLE VIII – Covenants of Parent and the Company > Section 8.02 Reasonable Best Efforts > (c)",
            "review_required": true
          },
          {
            "summary": "Parent is not obligated to take actions or agree to terms that would have a material adverse effect on the financial condition, business, or results of operations of the Company, Parent, and their Subsidiaries.",
            "section_or_clause_reference": "ARTICLE VIII – Covenants of Parent and the Company > Section 8.02 Reasonable Best Efforts > (b)",
            "review_required": true
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "prior_approval_commitment": [
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit mention of an obligation to obtain prior approval from a third party for future actions beyond the merger itself.",
        "clause_text": "The parties hereto agree that: (a) Subject to the terms and conditions of this Agreement, including Section 8.02(b) and Section 8.02(c), each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as practicable...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts"
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_obligations_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_process_control_discretion": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_process_control_discretion",
        "answer": "Parent",
        "summary": "Parent has control over regulatory process decisions, including the strategy for obtaining necessary approvals and leading communications with Governmental Authorities.",
        "confidence": 0.9,
        "reason": "The document specifies that Parent has the right to direct, devise, and implement the strategy for obtaining necessary approvals and leading communications with Governmental Authorities.",
        "clause_text": "Parent shall have the right to (i) direct, devise and implement the strategy for obtaining any necessary approval of, for responding to any request from, inquiry or investigation by (including directing the timing, nature and substance of all such responses), and shall have the right to lead all meetings and communications (including any negotiations) with, any Governmental Authority that has authority to enforce any Antitrust Law.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (c)"
      },
      {
        "section": "best_efforts",
        "field_name": "parent_has_sole_discretion_excluding_remedies",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that Parent shall consult with the Company and consider its views in regulatory matters, indicating shared control rather than sole discretion.",
        "clause_text": "Parent shall consult with the Company in a reasonable manner and consider in good faith the views and comments of the Company in connection with the foregoing.",
        "reference_section": "ARTICLE VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (c)"
      }
    ],
    "no_limitations_on_buyer_remedies": [
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_value",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly limits the Buyer's obligation to take Remedy Actions by stating that Parent is not required to take any action that would have a material adverse effect on the financial condition, business, or results of operations.",
        "clause_text": "Notwithstanding Section 8.02(a) or anything else in this Agreement to the contrary, nothing in this Agreement will obligate or require Parent, Merger Sub or any of their respective Subsidiaries to take or cause to be taken any action (or refrain or cause to refrain from taking any action) or agree or cause to agree to any term, condition or limitation ... if such action (or refraining from such action), term, condition or limitation would have or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the financial condition, business or results of operations of the Company, Parent and their respective Subsidiaries, taken as a whole, after giving effect to the Merger.",
        "reference_section": "ARTICLE VIII – COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The presence of material carveouts and qualifications in Section 8.02(b) indicates that the Buyer is not under a Hell-or-High-Water obligation.",
        "clause_text": "Notwithstanding Section 8.02(a) or anything else in this Agreement to the contrary, nothing in this Agreement will obligate or require Parent, Merger Sub or any of their respective Subsidiaries to take or cause to be taken any action (or refrain or cause to refrain from taking any action) or agree or cause to agree to any term, condition or limitation... if such action... would have or would reasonably be expected to have, individually or in the aggregate, a material adverse effect...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_explanation",
        "answer": "Not applicable",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_materiality_basis",
        "answer": "relative to combined company",
        "summary": "The agreement limits Buyer's obligation to take Remedy Actions based on materiality relative to the combined company, as it specifies that actions are not required if they would have a material adverse effect on the financial condition, business, or results of operations of the Company, Parent, and their respective Subsidiaries, taken as a whole, after the merger.",
        "confidence": 0.9,
        "reason": "The clause specifies that actions are not required if they would have a material adverse effect on the combined entity post-merger.",
        "clause_text": "nothing in this Agreement will obligate or require Parent, Merger Sub or any of their respective Subsidiaries to take or cause to be taken any action...if such action...would have or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the financial condition, business or results of operations of the Company, Parent and their respective Subsidiaries, taken as a whole, after giving effect to the Merger.",
        "reference_section": "ARTICLE VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "materiality_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "refiling_commitment": [
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document obligates the parties to use reasonable best efforts to comply with the HSR Act, including refiling if necessary.",
        "clause_text": "The parties hereto agree that: (a) Subject to the terms and conditions of this Agreement, including Section 8.02(b) and Section 8.02(c), each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as practicable, including (i) (A) preparing and filing as promptly as practicable with any Governmental Authority or other Third Party all documentation to effect all Filings as are necessary, proper or advisable to consummate the Merger and the other transactions contemplated hereby, (B) using reasonable best efforts to obtain, as promptly as practicable, and thereafter maintain, all Consents required to be obtained from any Governmental Authority or other Third Party that are necessary, proper or advisable to consummate the Merger or other transactions contemplated hereby, and complying with the terms and conditions of each Consent (including by supplying as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to the HSR Act or other applicable Antitrust Laws), and (C) cooperating, to the extent reasonable, with the other parties hereto in their efforts to comply with their obligations under this Agreement, including in seeking to obtain as promptly as practicable any required Consents",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_specification_status",
        "answer": "Not Specified",
        "summary": "The agreement does not specify a limit on the number of HSR refilings, nor does it state that refilings are unlimited.",
        "confidence": 0.8,
        "reason": "The agreement uses general language about using reasonable best efforts for filings but does not specify a limit or explicitly state unlimited refilings.",
        "clause_text": "The parties hereto agree that: (a) Subject to the terms and conditions of this Agreement, including Section 8.02(b) and Section 8.02(c), each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as practicable, including (i) (A) preparing and filing as promptly as practicable with any Governmental Authority or other Third Party all documentation to effect all Filings as are necessary, proper or advisable to consummate the Merger and the other transactions contemplated hereby...",
        "reference_section": "ARTICLE VIII – COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      }
    ],
    "union_item": [
      {
        "section": "best_efforts",
        "field_name": "union_efforts_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit language requiring efforts related to a labor union or employee representative organization.",
        "clause_text": "Neither the Company nor any of its Subsidiaries is, or since January 1, 2017 has been, a party to or subject to, or is currently negotiating in connection with entering into, any collective bargaining agreement or any other similar agreement with respect to employees of the Company or any of its Subsidiaries with any labor organization, labor union or other employee representative.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.19 Labor Matters"
      },
      {
        "section": "best_efforts",
        "field_name": "union_consultation_timeframe",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "union_agreement_obligation_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_strategy_control_rights": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_strategy_control_rights",
        "answer": "Parent has the right to control the regulatory strategy.",
        "summary": "Parent has the right to direct, devise, and implement the strategy for obtaining necessary approvals and to control the defense and settlement of any litigation related to Antitrust Law.",
        "confidence": 0.9,
        "reason": "The agreement explicitly grants Parent the right to direct and control regulatory strategy and litigation related to Antitrust Law.",
        "clause_text": "Parent shall have the right to (i) direct, devise and implement the strategy for obtaining any necessary approval of, for responding to any request from, inquiry or investigation by (including directing the timing, nature and substance of all such responses), and shall have the right to lead all meetings and communications (including any negotiations) with, any Governmental Authority that has authority to enforce any Antitrust Law and (ii) without limiting the generality of clause (i) of this Section 8.02(c) or the obligations of the Company under this Section 8.02, control the defense and settlement of any litigation, action, suit, investigation or proceeding brought by or before any Governmental Authority that has authority to enforce any Antitrust Law.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (c)"
      }
    ],
    "regulatory_delay_control_rights": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_delay_control_rights",
        "answer": "Parent has the right to control decisions that could delay or extend the regulatory review process.",
        "summary": "Parent has the right to direct, devise, and implement the strategy for obtaining necessary approvals and to control the defense and settlement of any litigation related to Antitrust Law.",
        "confidence": 0.9,
        "reason": "The agreement explicitly grants Parent the right to control regulatory strategy and litigation related to Antitrust Law.",
        "clause_text": "Parent shall have the right to (i) direct, devise and implement the strategy for obtaining any necessary approval of, for responding to any request from, inquiry or investigation by (including directing the timing, nature and substance of all such responses), and shall have the right to lead all meetings and communications (including any negotiations) with, any Governmental Authority that has authority to enforce any Antitrust Law and (ii) without limiting the generality of clause (i) of this Section 8.02(c) or the obligations of the Company under this Section 8.02, control the defense and settlement of any litigation, action, suit, investigation or proceeding brought by or before any Governmental Authority that has authority to enforce any Antitrust Law.",
        "reference_section": "ARTICLE VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (c)"
      }
    ],
    "remedy_consent_required_by_target": [
      {
        "section": "best_efforts",
        "field_name": "remedy_consent_required_by_target",
        "answer": "The agreement requires the target to obtain written consent from the acquirer before taking any regulatory remedial actions.",
        "summary": "The Company or its Affiliates cannot agree to any action in connection with obtaining Consents under Antitrust Laws without the prior written consent of Parent.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that the Company must obtain prior written consent from Parent for any obligations or actions related to obtaining Consents under Antitrust Laws.",
        "clause_text": "the Company or any of its Affiliates agree to any obligation, restriction, requirement, limitation, qualification, condition, remedy or other action in connection with obtaining the Consents under Antitrust Laws required to be obtained by the parties or their respective Subsidiaries in connection with the Merger without the prior written consent of Parent",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (g)"
      }
    ],
    "regulatory_review_discretion_rights": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_review_discretion_rights",
        "answer": "Parent has discretion authority over regulatory filings and procedural decisions.",
        "summary": "Parent has the right to direct, devise, and implement the strategy for obtaining necessary approvals and lead all meetings and communications with any Governmental Authority enforcing Antitrust Law.",
        "confidence": 0.9,
        "reason": "The document explicitly states that Parent has the right to direct and implement strategies for regulatory approvals.",
        "clause_text": "Parent shall have the right to (i) direct, devise and implement the strategy for obtaining any necessary approval of, for responding to any request from, inquiry or investigation by (including directing the timing, nature and substance of all such responses), and shall have the right to lead all meetings and communications (including any negotiations) with, any Governmental Authority that has authority to enforce any Antitrust Law.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (c)"
      }
    ]
  },
  "termination": {
    "outside_date": [
      {
        "section": "termination",
        "field_name": "primary_date",
        "answer": "January 2, 2020",
        "summary": "The initial 'Outside Date' specified in the agreement is January 2, 2020, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "the Merger has not been consummated on or before January 2, 2020 (as such date may be extended pursuant to the following proviso, the 'End Date');",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination > (b) > (i)"
      }
    ],
    "extension": [
      {
        "section": "termination",
        "field_name": "extension_list",
        "answer": [
          {
            "Extension Length": "60 days",
            "Who Grants the Extension": "either Parent or the Company",
            "Conditions to Extend": "if the conditions to the Closing set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to the matters referenced in Section 9.01(f)) shall not have been satisfied, but all other conditions to the Closing shall have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate or extend is not available to any party whose breach has been the proximate cause of the failure of the Merger to be consummated by such time"
          },
          {
            "Extension Length": "another 60 days",
            "Who Grants the Extension": "either Parent or the Company",
            "Conditions to Extend": "if on the date as extended by the first 60-day extension, the conditions to the Closing set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to the matters referenced in Section 9.01(f)) shall not have been satisfied, but all other conditions to the Closing shall have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate or extend is not available to any party whose breach has been the proximate cause of the failure of the Merger to be consummated by such time"
          }
        ],
        "summary": "The agreement allows for two potential 60-day extensions of the End Date, granted by either Parent or the Company, if specific closing conditions are unmet but all others are satisfied or waived. Termination or extension rights are restricted if a party's breach caused the failure to close.",
        "confidence": 0.95,
        "reason": "The agreement explicitly outlines conditions and parties involved in extending the End Date, with restrictions on parties in breach.",
        "clause_text": "provided that, (A) if on such date, the conditions to the Closing set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to the matters referenced in Section 9.01(f)) shall not have been satisfied, but all other conditions to the Closing shall have been satisfied (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on such date) or waived, then the End Date may be extended by either Parent or the Company for a period of sixty (60) days by written notice to the other party and (B) if on such date as extended by the immediately preceding clause (A), the conditions to the Closing set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to the matters referenced in Section 9.01(f)) shall not have been satisfied, but all other conditions to the Closing shall have been satisfied (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on such date) or waived, then the End Date may be further extended by either Parent or the Company for another period of sixty (60) days by written notice to the other party; provided, further, that the right to terminate this Agreement or to extend the End Date, as applicable, pursuant to this Section 10.01(b)(i) shall not be available to any party whose breach of any provision of this Agreement has been the proximate cause of the failure of the Merger to be consummated by such time;",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination"
      }
    ],
    "termination_fee": [
      {
        "section": "termination",
        "field_name": "termination_fee",
        "answer": "$2.2 billion",
        "summary": "The termination fee payable by the Target to the Parent, referred to as the 'Company Termination Fee,' is explicitly stated as $2.2 billion.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the 'Company Termination Fee')",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (a)"
      }
    ],
    "reverse_termination_fee": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee",
        "answer": "2.2 billion",
        "summary": "A reverse termination fee of $2.2 billion is payable by Parent to the Company if the agreement is terminated under certain conditions, such as a material breach by Parent or failure to obtain Parent Stockholder Approval.",
        "confidence": 0.9,
        "reason": "The agreement specifies a Parent Termination Fee of $2.2 billion payable to the Company under certain termination conditions.",
        "clause_text": "If this Agreement is terminated: (i) by the Company pursuant to Section 10.01(d)(i); (ii) by Parent pursuant to Section 10.01(c)(iii), (iii) by the Company or Parent pursuant to Section 10.01(b)(iv)... Parent shall pay to the Company, in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the 'Parent Termination Fee').",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (b)"
      }
    ],
    "reverse_termination_fee_exist": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_exist",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a provision for a Parent Termination Fee, which is a reverse termination fee, payable by Parent to the Company under certain conditions.",
        "clause_text": "If this Agreement is terminated: (i) by the Company pursuant to Section 10.01(d)(i); (ii) by Parent pursuant to Section 10.01(c)(iii), (iii) by the Company or Parent pursuant to Section 10.01(b)(iv)... then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), Parent shall pay to the Company, in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the 'Parent Termination Fee').",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (b)"
      }
    ],
    "termination_fee_superior_proposal": [
      {
        "section": "termination",
        "field_name": "termination_fee_superior_proposal_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly includes a provision requiring the Company to pay a fee to the Parent upon accepting a Superior Proposal.",
        "clause_text": "If this Agreement is terminated: (i) by Parent pursuant to Section 10.01(c)(i); (ii) by the Company pursuant to Section 10.01(d)(iii); ... then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the 'Company Termination Fee').",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (a)"
      },
      {
        "section": "termination",
        "field_name": "termination_fee_superior_proposal",
        "answer": "$2.2 billion",
        "summary": "The Company must pay a termination fee of $2.2 billion to the Parent if it terminates the agreement to pursue a Superior Proposal.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "If this Agreement is terminated: (i) by Parent pursuant to Section 10.01(c)(i); (ii) by the Company pursuant to Section 10.01(d)(iii); ... then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the 'Company Termination Fee').",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (a)"
      }
    ],
    "termination_fee_company_shareholder_approval": [
      {
        "section": "termination",
        "field_name": "termination_fee_company_shareholder_approval_failure_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a termination fee triggered by the failure to obtain shareholder approval, as specified in Section 10.03(a)(iii).",
        "clause_text": "If this Agreement is terminated: (iii) by the Company or Parent pursuant to Section 10.01(b)(iii), and in the case of clause (iii) of this sentence: (I) at or prior to the Company Stockholder Meeting a Company Acquisition Proposal shall have been publicly disclosed or announced and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Company Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Company Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Company Acquisition Proposal is entered into by the Company or any of its Affiliates; then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the \"Company Termination Fee\")",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (a)"
      },
      {
        "section": "termination",
        "field_name": "termination_fee_company_shareholder_approval_failure",
        "answer": "Not specified",
        "summary": "The document does not specify a termination fee for the failure to obtain shareholder approval without reference to a Superior Proposal or Adverse Recommendation Change.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "If this Agreement is terminated: (i) by Parent pursuant to Section 10.01(c)(i); (ii) by the Company pursuant to Section 10.01(d)(iii); (iii) by the Company or Parent pursuant to Section 10.01(b)(iii), and in the case of clause (iii) of this sentence: (I) at or prior to the Company Stockholder Meeting a Company Acquisition Proposal shall have been publicly disclosed or announced and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Company Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Company Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Company Acquisition Proposal is entered into by the Company or any of its Affiliates; or (iv) by Parent pursuant to Section 10.01(c)(ii) as a result of a material breach by the Company of its obligations set forth in Section 6.02 or Section 8.04(a) and, at the time of such termination, the Company Stockholder Approval shall not have been obtained, and in the case of clause (iv) of this sentence: (I) at or prior to the date of such termination a Company Acquisition Proposal shall have been made and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Company Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Company Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Company Acquisition Proposal is entered into by the Company or any of its Subsidiaries, then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the \"Company Termination Fee\") and (y) in the case of the foregoing clause (iii), the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to the Company Termination Fee, less any amounts paid to Parent (or its designee) as of such time with respect to the Parent Fee Reimbursement.",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (a)"
      }
    ],
    "reverse_termination_fee_shareholder_approval": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_shareholder_approval_failure_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no provision requiring the Parent to pay a Reverse Termination Fee upon failure to obtain its shareholder approval.",
        "clause_text": "If this Agreement is terminated: (i) by the Company pursuant to Section 10.01(d)(i); (ii) by Parent pursuant to Section 10.01(c)(iii), (iii) by the Company or Parent pursuant to Section 10.01(b)(iv), and in the case of clause (iii) of this sentence: (I) at or prior to the Parent Stockholder Meeting a Parent Acquisition Proposal shall have been publicly disclosed or announced and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Parent Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Parent Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Parent Acquisition Proposal is entered into by Parent or any of its Subsidiaries; or (iv) by the Company pursuant to Section 10.01(d)(ii) as a result of a material breach by Parent or Merger Sub of its obligations set forth in Section 7.02 or Section 8.04(b) and, at the time of such termination, the Parent Stockholder Approval shall not have been obtained, and in the case of clause (iv) of this sentence: (I) at or prior to the date of such termination a Parent Acquisition Proposal shall have been made and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Parent Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Parent Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Parent Acquisition Proposal is entered into by Parent or any of its Subsidiaries, then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), Parent shall pay to the Company, in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the \"Parent Termination Fee\") and (y) in the case of the foregoing clause (iii), Parent shall pay to the Company (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to the Parent Termination Fee, less any amounts paid to the Company (or its designee) as of such time with respect to the Company Fee Reimbursement.",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (b)"
      },
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_shareholder_approval_failure",
        "answer": "$2.2 billion",
        "summary": "If the agreement is terminated due to failure to obtain the Parent's shareholder approval, the Parent is obligated to pay the Company a fee of $2.2 billion.",
        "confidence": 0.95,
        "reason": "The document explicitly states the Parent Termination Fee amount in the event of termination due to failure to obtain shareholder approval.",
        "clause_text": "If this Agreement is terminated: (i) by the Company pursuant to Section 10.01(d)(i); (ii) by Parent pursuant to Section 10.01(c)(iii), (iii) by the Company or Parent pursuant to Section 10.01(b)(iv)... then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), Parent shall pay to the Company, in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the 'Parent Termination Fee').",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (b)"
      }
    ],
    "termination_rights": [
      {
        "section": "termination",
        "field_name": "mutual_termination_rights",
        "answer": [
          "the Merger has not been consummated on or before January 2, 2020",
          "a court or other Governmental Authority of competent jurisdiction shall have issued an injunction or other Order that permanently enjoins, prevents or prohibits the consummation of the Merger and such injunction or other Order shall have become final and non-appealable",
          "the Company Stockholder Approval shall not have been obtained upon a vote taken thereon at the Company Stockholder Meeting (including any adjournment or postponement thereof)",
          "the Parent Stockholder Approval shall not have been obtained upon a vote taken thereon at the Parent Stockholder Meeting (including any adjournment or postponement thereof)"
        ],
        "summary": "The agreement allows mutual termination if the merger is not consummated by January 2, 2020, if a final and non-appealable injunction prevents the merger, or if either the Company or Parent Stockholder Approval is not obtained.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "This Agreement may be terminated and the Merger and the other transactions contemplated hereby may be abandoned at any time prior to the Merger Effective Time... (b) by either the Company or Parent, if: (i) the Merger has not been consummated on or before January 2, 2020... (ii) a court or other Governmental Authority of competent jurisdiction shall have issued an injunction or other Order that permanently enjoins, prevents or prohibits the consummation of the Merger and such injunction or other Order shall have become final and non-appealable... (iii) the Company Stockholder Approval shall not have been obtained upon a vote taken thereon at the Company Stockholder Meeting (including any adjournment or postponement thereof); or (iv) the Parent Stockholder Approval shall not have been obtained upon a vote taken thereon at the Parent Stockholder Meeting (including any adjournment or postponement thereof);",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination"
      },
      {
        "section": "termination",
        "field_name": "parent_termination_rights",
        "answer": [
          "prior to the receipt of the Company Stockholder Approval, if (A) a Company Adverse Recommendation Change shall have occurred, or (B) at any time after a Company Acquisition Proposal shall have been publicly disclosed the Board of Directors of the Company shall have failed to publicly confirm the Company Board Recommendation within ten (10) Business Days after a written request by Parent that it do so (provided that Parent may not make such a request more than once for each (x) Company Acquisition Proposal or (y) material modification thereto)",
          "if a breach of any representation or warranty or failure to perform any covenant or agreement on the part of the Company set forth in this Agreement shall have occurred that would cause any condition set forth in Section 9.02(a) or Section 9.02(b) not to be satisfied, and such breach or failure to perform (A) is incapable of being cured by the End Date or (B) has not been cured by the Company within the earlier of (x) thirty (30) days following written notice to the Company from Parent of such breach or failure to perform and (y) the End Date; provided that this Agreement may not be terminated pursuant to this Section 10.01(c)(ii) if Parent or Merger Sub is then in breach of any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach by Parent or Merger Sub would cause any condition set forth in Section 9.03(a) or Section 9.03(b) not to be satisfied"
        ],
        "summary": "The Parent has the unilateral right to terminate the agreement if there is a Company Adverse Recommendation Change or if the Company breaches any representation, warranty, or covenant that cannot be cured by the End Date.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "by Parent: (i) prior to the receipt of the Company Stockholder Approval, if (A) a Company Adverse Recommendation Change shall have occurred, or (B) at any time after a Company Acquisition Proposal shall have been publicly disclosed the Board of Directors of the Company shall have failed to publicly confirm the Company Board Recommendation within ten (10) Business Days after a written request by Parent that it do so (provided that Parent may not make such a request more than once for each (x) Company Acquisition Proposal or (y) material modification thereto); (ii) if a breach of any representation or warranty or failure to perform any covenant or agreement on the part of the Company set forth in this Agreement shall have occurred that would cause any condition set forth in Section 9.02(a) or Section 9.02(b) not to be satisfied, and such breach or failure to perform (A) is incapable of being cured by the End Date or (B) has not been cured by the Company within the earlier of (x) thirty (30) days following written notice to the Company from Parent of such breach or failure to perform and (y) the End Date; provided that this Agreement may not be terminated pursuant to this Section 10.01(c)(ii) if Parent or Merger Sub is then in breach of any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach by Parent or Merger Sub would cause any condition set forth in Section 9.03(a) or Section 9.03(b) not to be satisfied",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination > (c)"
      },
      {
        "section": "termination",
        "field_name": "company_termination_rights",
        "answer": [
          "prior to the receipt of the Parent Stockholder Approval, if (A) a Parent Adverse Recommendation Change shall have occurred, or (B) at any time after a Parent Acquisition Proposal has been publicly disclosed the Board of Directors of Parent shall have failed to publicly confirm the Parent Board Recommendation within ten (10) Business Days after a written request by the Company that it do so",
          "if a breach of any representation or warranty or failure to perform any covenant or agreement on the part of Parent or Merger Sub set forth in this Agreement shall have occurred that would cause any condition set forth in Section 9.03(a) or Section 9.03(b) not to be satisfied, and such breach or failure to perform (A) is incapable of being cured by the End Date or (B) has not been cured by Parent or Merger Sub, as applicable, within the earlier of (x) thirty (30) days following written notice to Parent from the Company of such breach or failure to perform and (y) the End Date",
          "prior to obtaining the Company Stockholder Approval, in order to enter into a definitive agreement providing for a Company Superior Proposal in accordance with, and subject to the terms and conditions of, Section 6.02"
        ],
        "summary": "The Company can terminate the agreement if there is a Parent Adverse Recommendation Change, a breach by Parent or Merger Sub that cannot be cured, or to accept a Company Superior Proposal.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "by the Company: (i) prior to the receipt of the Parent Stockholder Approval, if (A) a Parent Adverse Recommendation Change shall have occurred, or (B) at any time after a Parent Acquisition Proposal has been publicly disclosed the Board of Directors of Parent shall have failed to publicly confirm the Parent Board Recommendation within ten (10) Business Days after a written request by the Company that it do so; (ii) if a breach of any representation or warranty or failure to perform any covenant or agreement on the part of Parent or Merger Sub set forth in this Agreement shall have occurred that would cause any condition set forth in Section 9.03(a) or Section 9.03(b) not to be satisfied, and such breach or failure to perform (A) is incapable of being cured by the End Date or (B) has not been cured by Parent or Merger Sub, as applicable, within the earlier of (x) thirty (30) days following written notice to Parent from the Company of such breach or failure to perform and (y) the End Date; (iii) prior to obtaining the Company Stockholder Approval, in order to enter into a definitive agreement providing for a Company Superior Proposal in accordance with, and subject to the terms and conditions of, Section 6.02.",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination > (d)"
      }
    ],
    "termination_fee_events": [
      {
        "section": "termination",
        "field_name": "company_termination_fee_events",
        "answer": [
          "Termination by Parent pursuant to Section 10.01(c)(i)",
          "Termination by the Company pursuant to Section 10.01(d)(iii)",
          "Termination by the Company or Parent pursuant to Section 10.01(b)(iii) if a Company Acquisition Proposal is publicly disclosed and not withdrawn, and a related transaction is consummated or a definitive agreement is entered into within one year",
          "Termination by Parent pursuant to Section 10.01(c)(ii) due to a material breach by the Company, if a Company Acquisition Proposal is made and not withdrawn, and a related transaction is consummated or a definitive agreement is entered into within one year"
        ],
        "summary": "The Company is required to pay a termination fee under specific scenarios including termination by Parent or Company under certain sections, especially if a Company Acquisition Proposal is involved and leads to a transaction or agreement within a year.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "If this Agreement is terminated: (i) by Parent pursuant to Section 10.01(c)(i); (ii) by the Company pursuant to Section 10.01(d)(iii); (iii) by the Company or Parent pursuant to Section 10.01(b)(iii), and in the case of clause (iii) of this sentence: (I) at or prior to the Company Stockholder Meeting a Company Acquisition Proposal shall have been publicly disclosed or announced and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Company Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Company Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Company Acquisition Proposal is entered into by the Company or any of its Affiliates; or (iv) by Parent pursuant to Section 10.01(c)(ii) as a result of a material breach by the Company of its obligations set forth in Section 6.02 or Section 8.04(a) and, at the time of such termination, the Company Stockholder Approval shall not have been obtained, and in the case of clause (iv) of this sentence: (I) at or prior to the date of such termination a Company Acquisition Proposal shall have been made and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Company Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Company Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Company Acquisition Proposal is entered into by the Company or any of its Subsidiaries, then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the \"Company Termination Fee\")",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (a)"
      },
      {
        "section": "termination",
        "field_name": "parent_reverse_termination_fee_events",
        "answer": [
          "Termination by the Company pursuant to Section 10.01(d)(i)",
          "Termination by Parent pursuant to Section 10.01(c)(iii)",
          "Termination by the Company or Parent pursuant to Section 10.01(b)(iv) with a Parent Acquisition Proposal publicly disclosed and not withdrawn, followed by a consummated transaction or definitive agreement within one year",
          "Termination by the Company pursuant to Section 10.01(d)(ii) due to a material breach by Parent or Merger Sub, with a Parent Acquisition Proposal publicly disclosed and not withdrawn, followed by a consummated transaction or definitive agreement within one year"
        ],
        "summary": "The Parent is required to pay a reverse termination fee under specific termination scenarios, including breaches by Parent or Merger Sub and certain acquisition proposals.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "If this Agreement is terminated: (i) by the Company pursuant to Section 10.01(d)(i); (ii) by Parent pursuant to Section 10.01(c)(iii), (iii) by the Company or Parent pursuant to Section 10.01(b)(iv), and in the case of clause (iii) of this sentence: (I) at or prior to the Parent Stockholder Meeting a Parent Acquisition Proposal shall have been publicly disclosed or announced and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Parent Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Parent Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Parent Acquisition Proposal is entered into by Parent or any of its Subsidiaries; or (iv) by the Company pursuant to Section 10.01(d)(ii) as a result of a material breach by Parent or Merger Sub of its obligations set forth in Section 7.02 or Section 8.04(b) and, at the time of such termination, the Parent Stockholder Approval shall not have been obtained, and in the case of clause (iv) of this sentence: (I) at or prior to the date of such termination a Parent Acquisition Proposal shall have been made and shall not have been publicly and irrevocably withdrawn at least four (4) days prior to the Parent Stockholder Meeting; and (II) within the first (1st) anniversary of such termination of this Agreement: (1) a transaction relating to any Parent Acquisition Proposal is consummated; or (2) a definitive agreement relating to any Parent Acquisition Proposal is entered into by Parent or any of its Subsidiaries, then (x) in the case of each of the foregoing clauses (i), (ii) and (iv), Parent shall pay to the Company, in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the \"Parent Termination Fee\") and (y) in the case of the foregoing clause (iii), Parent shall pay to the Company (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to the Parent Termination Fee, less any amounts paid to the Company (or its designee) as of such time with respect to the Company Fee Reimbursement.",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (b)"
      }
    ],
    "reimbursement_obligations": [
      {
        "section": "termination",
        "field_name": "target_reimbursement_obligations",
        "answer": "The Company shall pay to Parent (or its designee) an amount equal to all out-of-pocket costs, fees and expenses (including legal fees and expenses) incurred by Parent and any of its Affiliates in connection with this Agreement and the transactions contemplated hereby, subject to cap on such reimbursement of $40,000,000 ('Parent Fee Reimbursement').",
        "summary": "The Company is obligated to reimburse Parent for all out-of-pocket costs, fees, and expenses incurred in connection with the Agreement, capped at $40,000,000.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the Company's obligation to reimburse Parent for specified expenses, capped at $40,000,000.",
        "clause_text": "If this Agreement is terminated by Parent or the Company pursuant to Section 10.01(b)(iii), then the Company shall pay to Parent (or its designee) an amount equal to all out-of-pocket costs, fees and expenses (including legal fees and expenses) incurred by Parent and any of its Affiliates in connection with this Agreement and the transactions contemplated hereby (including obtaining the Debt Financing), subject to cap on such reimbursement of $40,000,000 ('Parent Fee Reimbursement'), within one Business Day after the date of the termination of the Agreement (in the case of any such termination by Parent) or at or prior to, and as a condition precedent to, the termination of the Agreement (in the case of any such termination by the Company).",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (c)"
      },
      {
        "section": "termination",
        "field_name": "parent_reimbursement_obligations",
        "answer": "Parent shall reimburse the Company for all reasonable and documented out-of-pocket costs and expenses incurred in connection with the Debt Financing or any Company Note Offers and Consent Solicitations.",
        "summary": "Parent is obligated to reimburse the Company for reasonable and documented out-of-pocket costs and expenses related to the Debt Financing or Company Note Offers and Consent Solicitations.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent shall reimburse the Company for costs and expenses related to specific financial activities.",
        "clause_text": "Parent and Merger Sub shall, on a joint and several basis, promptly upon written request by the Company, reimburse the Company for all reasonable and documented out-of-pocket costs and expenses (including reasonable attorneys' fees) incurred by the Company or any of its Subsidiaries in connection with the Debt Financing or any Company Note Offers and Consent Solicitations or satisfying its obligations under this Section 6.03 or Section 6.04, whether or not the Merger is consummated or this Agreement is terminated.",
        "reference_section": "ARTICLE VI – COVENANTS OF THE COMPANY > Section 6.03 Financing Assistance > (c)"
      }
    ],
    "regulatory_termination_fee": [
      {
        "section": "termination",
        "field_name": "regulatory_termination_fee",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "failure_to_close_fee": [
      {
        "section": "termination",
        "field_name": "failure_to_close_fee",
        "answer": "$2.2 billion",
        "summary": "A termination fee of $2.2 billion is payable by either the Company or Parent if the agreement is terminated under specified conditions, including failure to close.",
        "confidence": 0.9,
        "reason": "The document specifies a termination fee of $2.2 billion payable under certain termination conditions.",
        "clause_text": "If this Agreement is terminated: (i) by Parent pursuant to Section 10.01(c)(i); (ii) by the Company pursuant to Section 10.01(d)(iii); (iii) by the Company or Parent pursuant to Section 10.01(b)(iii)... the Company shall pay to Parent (or its designee), in cash at the time specified in the following sentence, a fee in an amount equal to $2.2 billion (the 'Company Termination Fee').",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.03 Termination Fees > (a)"
      }
    ],
    "reverse_termination_fee_regulatory": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_regulatory",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "extend_or_terminate_limitation_due_to_breach": [
      {
        "section": "termination",
        "field_name": "extend_or_terminate_limitation_due_to_breach",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "ordinary_course": {
    "ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "concise_standard_summary",
        "answer": "Parent shall use commercially reasonable efforts to conduct its business in all material respects in the ordinary course of business consistent with past practice.",
        "summary": "Parent is required to use commercially reasonable efforts to operate its business in the ordinary course consistent with past practices between signing and closing.",
        "confidence": 0.9,
        "reason": "The document specifies that Parent must use commercially reasonable efforts to conduct its business in the ordinary course consistent with past practice.",
        "clause_text": "Parent shall, and shall cause each of its Subsidiaries to, use commercially reasonable efforts to conduct its business in all material respects in the ordinary course of business consistent with past practice;",
        "reference_section": "ARTICLE VII COVENANTS OF PARENT > Section 7.01 Conduct of Parent"
      }
    ],
    "parent_ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "parent_conduct_covenant_summary",
        "answer": "Parent is obligated to use commercially reasonable efforts to conduct its business in the ordinary course consistent with past practice, maintain financing, and cooperate with the Company regarding regulatory actions.",
        "summary": "Parent must use commercially reasonable efforts to conduct its business in the ordinary course, maintain financing, and cooperate with the Company on regulatory actions.",
        "confidence": 0.9,
        "reason": "The document outlines specific obligations for Parent to maintain business operations, financing, and regulatory cooperation.",
        "clause_text": "Parent shall, and shall cause each of its Subsidiaries to, use commercially reasonable efforts to conduct its business in all material respects in the ordinary course of business consistent with past practice; provided that (i) no action by the Parent or any of its Subsidiaries to the extent expressly permitted by an exception to any of Section 7.01(a) through Section 7.01(f) will be a breach of this sentence.",
        "reference_section": "ARTICLE Article VII COVENANTS OF PARENT > Section 7.01 Conduct of Parent"
      }
    ]
  },
  "board_approval": {
    "board_approval": [
      {
        "section": "board_approval",
        "field_name": "target_board_approval",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger agreement explicitly states that the Board of Directors of the Company has unanimously approved the transaction.",
        "clause_text": "At a meeting duly called and held, the Board of Directors of the Company unanimously adopted resolutions (i) determining that this Agreement and the transactions contemplated hereby (including the Merger) are fair to and in the best interests of the Company and its stockholders, (ii) approving, adopting and declaring advisable this Agreement and the transactions contemplated hereby (including the Merger).",
        "reference_section": "ARTICLE IV – REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.02 Corporate Authorization > (b)"
      },
      {
        "section": "board_approval",
        "field_name": "target_board_unanimous",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Board of Directors of the Company unanimously adopted resolutions approving the agreement.",
        "clause_text": "At a meeting duly called and held, the Board of Directors of the Company unanimously adopted resolutions (i) determining that this Agreement and the transactions contemplated hereby (including the Merger) are fair to and in the best interests of the Company and its stockholders, (ii) approving, adopting and declaring advisable this Agreement and the transactions contemplated hereby (including the Merger)...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.02 Corporate Authorization"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_approval",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Board of Directors of Parent has approved the agreement and the transactions contemplated by it.",
        "clause_text": "At a meeting duly called and held, the Board of Directors of Parent adopted resolutions (i) determining that this Agreement and the transactions contemplated hereby (including the Parent Share Issuance) are fair to and in the best interests of Parent and its stockholders, (ii) approving, adopting and declaring advisable this Agreement and the transactions contemplated hereby (including the Parent Share Issuance).",
        "reference_section": "ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.02 Corporate Authorization > (b)"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_unanimous",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of unanimous approval by the Parent Board in the provided excerpts.",
        "clause_text": "The Board of Directors of Parent adopted resolutions (i) determining that this Agreement and the transactions contemplated hereby (including the Parent Share Issuance) are fair to and in the best interests of Parent and its stockholders, (ii) approving, adopting and declaring advisable this Agreement and the transactions contemplated hereby (including the Parent Share Issuance), (iii) directing that the approval of the Parent Share Issuance be submitted to a vote at a meeting of Parent's stockholders and (iv) recommending approval of the Parent Share Issuance by Parent's stockholders.",
        "reference_section": "ARTICLE Article V REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.02 Corporate Authorization"
      }
    ]
  },
  "party_details": {
    "acquirer": [
      {
        "section": "party_details",
        "field_name": "acquirer",
        "answer": "Bristol-Myers Squibb Company",
        "summary": "The acquiring entity in the agreement is Bristol-Myers Squibb Company, which is identified as the 'Parent' in the transaction.",
        "confidence": 0.95,
        "reason": "The Preamble of the agreement explicitly names Bristol-Myers Squibb Company as the 'Parent,' which is the acquiring entity.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of January 2, 2019 is by and among Bristol-Myers Squibb Company, a Delaware corporation (\"Parent\"), Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent (\"Merger Sub\"), and Celgene Corporation, a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "party_details",
        "field_name": "parent_entity_details",
        "answer": "Bristol-Myers Squibb Company",
        "summary": "Bristol-Myers Squibb Company is the ultimate parent company of Burgundy Merger Sub, Inc., which is a direct, wholly owned subsidiary of Bristol-Myers Squibb Company.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states that Burgundy Merger Sub, Inc. is a direct, wholly owned subsidiary of Bristol-Myers Squibb Company.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of January 2, 2019 is by and among Bristol-Myers Squibb Company, a Delaware corporation (\"Parent\"), Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent (\"Merger Sub\"), and Celgene Corporation, a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "target": [
      {
        "section": "party_details",
        "field_name": "target",
        "answer": "Celgene Corporation",
        "summary": "The target company being acquired is Celgene Corporation, as identified in the agreement.",
        "confidence": 1.0,
        "reason": "The agreement explicitly defines Celgene Corporation as 'the Company' being acquired.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of January 2, 2019 is by and among Bristol-Myers Squibb Company, a Delaware corporation (\"Parent\"), Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent (\"Merger Sub\"), and Celgene Corporation, a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "guarantor": [
      {
        "section": "party_details",
        "field_name": "guarantor_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly mention the presence of a guarantor for any obligations.",
        "clause_text": "The obligations of Parent and Merger Sub hereunder are not conditioned in any manner upon Parent or Merger Sub obtaining any financing.",
        "reference_section": "ARTICLE Article V REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.27 Financing"
      },
      {
        "section": "party_details",
        "field_name": "guarantor_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "subsidiaries": [
      {
        "section": "party_details",
        "field_name": "target_subsidiaries_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit reference to any subsidiaries of the target company being directly involved in the merger structure.",
        "clause_text": "The execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated hereby do not and will not (a) contravene, conflict with, or result in any violation or breach of any provision of the Company Organizational Documents...",
        "reference_section": "ARTICLE IV – REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.04 – Non-contravention"
      },
      {
        "section": "party_details",
        "field_name": "target_subsidiaries",
        "answer": "No target subsidiaries explicitly involved in the merger structure are mentioned.",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "Merger Sub, a wholly owned subsidiary of Parent, is explicitly referenced as being directly involved in the merger structure.",
        "clause_text": "Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent (\"Merger Sub\"), and Celgene Corporation, a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries",
        "answer": "[{ \"name\": \"Burgundy Merger Sub, Inc.\", \"clause_reference\": \"Preamble\", \"role\": \"Wholly owned merger vehicle used to merge with the target\" }]",
        "summary": "Burgundy Merger Sub, Inc., a wholly owned subsidiary of the Parent, is explicitly involved as the merger vehicle to merge with the target.",
        "confidence": 0.95,
        "reason": "The Preamble explicitly identifies Burgundy Merger Sub, Inc. as a wholly owned subsidiary of the Parent and as the merger vehicle.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of January 2, 2019 is by and among Bristol-Myers Squibb Company, a Delaware corporation (\"Parent\"), Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent (\"Merger Sub\"), and Celgene Corporation, a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "transaction": [
      {
        "section": "party_details",
        "field_name": "transaction_type",
        "answer": "Reverse Triangular Merger",
        "summary": "The transaction involves Merger Sub merging into the Company, with the Company surviving, which is characteristic of a Reverse Triangular Merger.",
        "confidence": 0.95,
        "reason": "The structure described involves a subsidiary (Merger Sub) merging into the target (Company) with the target surviving, which is a standard Reverse Triangular Merger.",
        "clause_text": "At the Merger Effective Time, Merger Sub shall be merged with and into the Company in accordance with the DGCL (the 'Merger'), whereupon the separate existence of Merger Sub shall cease, and the Company shall survive as the surviving corporation in the merger (the 'Surviving Corporation').",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.02 The Merger > (b)"
      },
      {
        "section": "party_details",
        "field_name": "transaction_structure_notes",
        "answer": "At the Merger Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease, and the Company shall survive as the surviving corporation.",
        "summary": "The transaction is structured as a merger where Merger Sub will merge into the Company, and the Company will continue as the surviving corporation.",
        "confidence": 0.95,
        "reason": "The structure involves the merger of Merger Sub into the Company, with the Company surviving.",
        "clause_text": "At the Merger Effective Time, Merger Sub shall be merged with and into the Company in accordance with the DGCL (the \"Merger\"), whereupon the separate existence of Merger Sub shall cease, and the Company shall survive as the surviving corporation in the merger (the \"Surviving Corporation\").",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.02 The Merger > (b)"
      }
    ],
    "merger_sub_details": [
      {
        "section": "party_details",
        "field_name": "merger_sub_details",
        "answer": "Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent",
        "summary": "Burgundy Merger Sub, Inc. is a Delaware corporation and a direct, wholly owned subsidiary of the Parent, Bristol-Myers Squibb Company.",
        "confidence": 1.0,
        "reason": "The Preamble explicitly states the full legal name, jurisdiction, and ownership relationship of the Merger Sub.",
        "clause_text": "Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent",
        "reference_section": "ARTICLE Preamble"
      }
    ]
  },
  "closing_mechanics": {
    "target_date": [
      {
        "section": "closing_mechanics",
        "field_name": "target_date",
        "answer": "3rd Business Day after satisfaction of conditions in Article IX",
        "summary": "The closing of the Merger is set to occur on the third Business Day after the conditions in Article IX are satisfied or waived, unless another date is mutually agreed upon by the parties.",
        "confidence": 0.9,
        "reason": "The clause specifies the closing date as the third Business Day after the satisfaction or waiver of conditions in Article IX.",
        "clause_text": "The closing of the Merger (the \"Closing\") shall take place in New York City at the offices of Kirkland & Ellis LLP, 601 Lexington Avenue, New York, New York, 10022 at 10:00 a.m., Eastern time, on the third (3rd) Business Day after the date the conditions set forth in Article IX (other than conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent permitted by Applicable Law, waiver of such conditions by the party or parties entitled to the benefit thereof at the Closing) have been satisfied or, to the extent permitted by Applicable Law, waived by the party or parties entitled to the benefit thereof, or at such other place, at such other time or on such other date as Parent and the Company may mutually agree (the date on which the Closing occurs, the \"Closing Date\").",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.01 Closing"
      }
    ],
    "marketing_period": [
      {
        "section": "closing_mechanics",
        "field_name": "has_marketing_period",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The term 'Marketing Period' is not mentioned or explicitly referenced in connection with financing, deliverables, or closing timing in the provided excerpts.",
        "clause_text": "The excerpts provided do not contain any mention of a 'Marketing Period' or similar concept.",
        "reference_section": "ARTICLE VII COVENANTS OF PARENT > Section 7.06 Financing"
      },
      {
        "section": "closing_mechanics",
        "field_name": "marketing_period_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "closing_mechanics",
        "field_name": "has_inside_date",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly define or reference an 'Inside Date' as a deadline or milestone prior to the Outside Date.",
        "clause_text": "This Agreement may be terminated and the Merger and the other transactions contemplated hereby may be abandoned at any time prior to the Merger Effective Time (notwithstanding receipt of the Company Stockholder Approval or the Parent Stockholder Approval): (a) by mutual written agreement of the Company and Parent; (b) by either the Company or Parent, if: (i) the Merger has not been consummated on or before January 2, 2020 (as such date may be extended pursuant to the following proviso, the 'End Date');",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination"
      },
      {
        "section": "closing_mechanics",
        "field_name": "inside_date_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "specific_performance": {
    "specific_performance": [
      {
        "section": "specific_performance",
        "field_name": "specific_performance_available",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement expressly states that the parties are entitled to specifically enforce the terms and provisions of the Agreement.",
        "clause_text": "It is accordingly agreed that, except where this Agreement is validly terminated in accordance with Section 10.01, the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages, and each party further agrees to waive any requirement for the securing or posting of any bond in connection with such remedy.",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_parties",
        "answer": "Company, Parent",
        "summary": "Both the Company and Parent are entitled to seek specific performance as per the agreement terms.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the parties, which include the Company and Parent, are entitled to seek specific performance.",
        "clause_text": "It is accordingly agreed that, except where this Agreement is validly terminated in accordance with Section 10.01, the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages...",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_limitations",
        "answer": "The right to seek specific performance is limited by the condition that the Agreement must not be validly terminated in accordance with Section 10.01.",
        "summary": "Specific performance can be sought unless the Agreement is validly terminated under Section 10.01, and parties cannot seek both specific performance and termination fees simultaneously.",
        "confidence": 0.9,
        "reason": "The clause specifies that specific performance is available unless the Agreement is terminated under Section 10.01.",
        "clause_text": "It is accordingly agreed that, except where this Agreement is validly terminated in accordance with Section 10.01, the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages...",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_condition",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that Parent's and Merger Sub's obligations are not conditioned upon obtaining any financing.",
        "clause_text": "Parent expressly acknowledges and agrees that Parent's and Merger Sub's obligations hereunder are not conditioned in any manner upon Parent or Merger Sub obtaining any financing.",
        "reference_section": "ARTICLE VII COVENANTS OF PARENT > Section 7.06 Financing > (e)"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_details",
        "answer": "Parent's and Merger Sub's obligations are not conditioned on obtaining financing.",
        "summary": "The agreement explicitly states that Parent's and Merger Sub's obligations are not conditioned upon obtaining any financing.",
        "confidence": 0.95,
        "reason": "The clause clearly states that the obligations are not conditioned on financing.",
        "clause_text": "Notwithstanding anything contained in this Agreement to the contrary, Parent expressly acknowledges and agrees that Parent's and Merger Sub's obligations hereunder are not conditioned in any manner upon Parent or Merger Sub obtaining any financing.",
        "reference_section": "ARTICLE VII COVENANTS OF PARENT > Section 7.06 Financing > (e)"
      }
    ]
  },
  "confidentiality_and_clean_room": {
    "confidentiality": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly references a 'Confidentiality Agreement' between the parties.",
        "clause_text": "This Agreement and the Confidentiality Agreement constitute the entire agreement between the parties with respect to the subject matter thereof and supersede all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter thereof.",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.11 Entire Agreement"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_agreement_date",
        "answer": "November 23, 2018",
        "summary": "The confidentiality agreement was referenced as being dated November 23, 2018, in the agreement.",
        "confidence": 0.9,
        "reason": "The confidentiality agreement is explicitly dated as of November 23, 2018.",
        "clause_text": "All information furnished pursuant to this Agreement shall be subject to the letter agreement, dated as of November 23, 2018 (as amended, supplemented or otherwise modified from time to time in accordance with its terms, the \"Confidentiality Agreement\"), between Parent and the Company.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.01 Access to Information; Confidentiality"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_obligation_termination_date",
        "answer": "The confidentiality obligations extend post-termination.",
        "summary": "The termination of the Agreement does not affect the parties' respective obligations under the Confidentiality Agreement.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that termination does not affect confidentiality obligations.",
        "clause_text": "In addition, the termination of this Agreement shall not affect the parties' respective obligations under the Confidentiality Agreement.",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.02 Effect of Termination"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_amendment_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit mention of any amendment or modification to the confidentiality agreement.",
        "clause_text": "This Agreement and the Confidentiality Agreement constitute the entire agreement between the parties with respect to the subject matter thereof and supersede all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter thereof.",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.11 Entire Agreement"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_amendment_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "clean_room": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no reference to a Clean Room or Clean Team arrangement in the provided excerpts.",
        "clause_text": "The provided sections do not mention a Clean Room or Clean Team arrangement.",
        "reference_section": "confidentiality_and_clean_room > clean_room"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_signing_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_start_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_end_date",
        "answer": "the earlier of the Merger Effective Time and the termination of this Agreement",
        "summary": "Clean Room access terminates at the earlier of the Merger Effective Time and the termination of this Agreement.",
        "confidence": 0.9,
        "reason": "The language specifies that certain obligations, including those related to the Clean Room, end at the earlier of the Merger Effective Time or the termination of the Agreement.",
        "clause_text": "From the date of this Agreement until the earlier of the Merger Effective Time and the termination of this Agreement...",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_scope_restrictions",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no clause that explicitly results in suspension, revocation, or restriction of the Company’s access to clean room or confidential data in connection with a Superior Proposal.",
        "clause_text": "The excerpts provided do not contain any language that directly addresses the suspension, revocation, or restriction of access to clean room or confidential data in connection with a Superior Proposal.",
        "reference_section": "ARTICLE Article VII COVENANTS OF PARENT > Section 7.02 No Solicitation by Parent"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_summary",
        "answer": "The agreement implies that the Company's access to confidential information may be restricted in connection with a Superior Proposal.",
        "summary": "The Company must use reasonable efforts to terminate discussions with third parties and ensure the return or destruction of confidential information if a Superior Proposal is made.",
        "confidence": 0.9,
        "reason": "The clause requires the Company to terminate discussions and return or destroy confidential information if a Superior Proposal is made.",
        "clause_text": "The Company shall use its reasonable best efforts to cause any such party (and any of its Representatives) in possession of confidential information about the Company or any of its Subsidiaries that was furnished by or on behalf of the Company to return or destroy all such information.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.02 No Solicitation by the Company > (h)"
      }
    ]
  },
  "complex_consideration_and_dividends": {
    "deal_consideration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_overview",
        "answer": "Each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive one share of Parent Common Stock, $50.00 in cash without interest, and one contingent value right issued by Parent.",
        "summary": "The total consideration offered to target shareholders includes one share of Parent Common Stock, $50.00 in cash, and one contingent value right per share of Company Common Stock.",
        "confidence": 1.0,
        "reason": "The document explicitly states the components of the Merger Consideration.",
        "clause_text": "each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the \"Exchange Ratio\") share of Parent Common Stock (the \"Share Consideration\"), subject to Section 2.08 with respect to fractional shares, (B) $50.00 in cash without interest (the \"Cash Consideration\") and (C) one contingent value right (a \"New CVR\") issued by Parent subject to and in accordance with the New CVR Agreement (the consideration contemplated by subclauses (A), (B) and (C) together, the \"Merger Consideration\");",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_details",
        "answer": "Each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive one share of Parent Common Stock, $50.00 in cash without interest, and one contingent value right (CVR) issued by Parent.",
        "summary": "The merger consideration consists of one share of Parent Common Stock, $50.00 in cash, and one contingent value right (CVR) per share of Company Common Stock.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the \"Exchange Ratio\") share of Parent Common Stock (the \"Share Consideration\"), subject to Section 2.08 with respect to fractional shares, (B) $50.00 in cash without interest (the \"Cash Consideration\") and (C) one contingent value right (a \"New CVR\") issued by Parent subject to and in accordance with the New CVR Agreement",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      }
    ],
    "proration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not mention any proration between different types of consideration such as stock versus cash.",
        "clause_text": "At the Merger Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or the holders of the Company Common Stock: (a) other than (i) shares of Company Common Stock to be cancelled pursuant to Section 2.03(b) and (ii) Dissenting Shares (such shares together with the shares of Company Common Stock to be cancelled pursuant to Section 2.03(b), collectively, the 'Excluded Shares'), each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the 'Exchange Ratio') share of Parent Common Stock (the 'Share Consideration'), subject to Section 2.08 with respect to fractional shares, (B) $50.00 in cash without interest (the 'Cash Consideration') and (C) one contingent value right (a 'New CVR') issued by Parent subject to and in accordance with the New CVR Agreement (the consideration contemplated by subclauses (A), (B) and (C) together, the 'Merger Consideration');",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "election": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not provide any indication that shareholders are allowed to elect among different types of consideration.",
        "clause_text": "At the Merger Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or the holders of the Company Common Stock: (a) other than (i) shares of Company Common Stock to be cancelled pursuant to Section 2.03(b) and (ii) Dissenting Shares (such shares together with the shares of Company Common Stock to be cancelled pursuant to Section 2.03(b), collectively, the 'Excluded Shares'), each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the 'Exchange Ratio') share of Parent Common Stock (the 'Share Consideration'), subject to Section 2.08 with respect to fractional shares, (B) $50.00 in cash without interest (the 'Cash Consideration') and (C) one contingent value right (a 'New CVR') issued by Parent subject to and in accordance with the New CVR Agreement (the consideration contemplated by subclauses (A), (B) and (C) together, the 'Merger Consideration');",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_details",
        "answer": "No election is permitted and consideration is fixed.",
        "summary": "Shareholders are not allowed to choose the form of consideration; each share of Company Common Stock is automatically converted into a fixed combination of Parent Common Stock, cash, and a contingent value right.",
        "confidence": 0.9,
        "reason": "The agreement specifies a fixed conversion of shares into a combination of stock, cash, and contingent value rights without mention of any election process.",
        "clause_text": "At the Merger Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or the holders of the Company Common Stock: (a) ... each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the 'Exchange Ratio') share of Parent Common Stock (the 'Share Consideration'), (B) $50.00 in cash without interest (the 'Cash Consideration') and (C) one contingent value right (a 'New CVR') issued by Parent subject to and in accordance with the New CVR Agreement...",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      }
    ],
    "cvr": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger consideration explicitly includes a Contingent Value Right (CVR) as part of the Merger Consideration.",
        "clause_text": "each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the \"Exchange Ratio\") share of Parent Common Stock (the \"Share Consideration\"), subject to Section 2.08 with respect to fractional shares, (B) $50.00 in cash without interest (the \"Cash Consideration\") and (C) one contingent value right (a \"New CVR\") issued by Parent subject to and in accordance with the New CVR Agreement",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_details",
        "answer": "The agreement includes a Contingent Value Right (CVR) as part of the Merger Consideration.",
        "summary": "The agreement includes a Contingent Value Right (CVR) as part of the Merger Consideration, which is issued by Parent subject to and in accordance with the New CVR Agreement.",
        "confidence": 0.9,
        "reason": "The presence of a CVR is explicitly mentioned as part of the Merger Consideration in the agreement.",
        "clause_text": "each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive ... one contingent value right (a 'New CVR') issued by Parent subject to and in accordance with the New CVR Agreement",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      }
    ],
    "ticking_fees": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not include any provision for a ticking fee, time-based fee, or incremental increase in consideration payable over time due to delay.",
        "clause_text": "The provided sections discuss termination fees and reimbursements but do not mention any ticking fees or similar provisions.",
        "reference_section": "ARTICLE X TERMINATION > Section 10.03 Termination Fees"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "contingent_payments": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document mentions contingent payments beyond CVRs, specifically referring to 'earn-out', contingent value rights or other contingent payment or value obligations.",
        "clause_text": "including \"earn-out\", contingent value rights or other contingent payment or value obligations) that would reasonably be expected to involve or may require the receipt or making of payments or the issuance of any Equity Securities of the Company or any of its Subsidiaries in excess of $250,000,000 in the fiscal year ending December 31, 2018 or any fiscal year thereafter",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.16 Material Contracts > (a) > (ii) > (B)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "company_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly prohibits the Company from declaring or paying any dividends without Parent's prior written consent.",
        "clause_text": "Without limiting the generality of the foregoing, except (A) as prohibited or required by Applicable Law, (B) as set forth in Section 6.01 of the Company Disclosure Schedule, or (C) as otherwise required or expressly contemplated by this Agreement, without Parent's prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed), the Company shall not, and shall cause each of its Subsidiaries not to: (c) (iii) declare, set aside or pay any dividend or make any other distribution (whether in cash, stock, property or any combination thereof) in respect of any shares of its capital stock or other Equity Securities, other than dividends or distributions by a Subsidiary of the Company to the Company or a wholly owned Subsidiary of the Company.",
        "reference_section": "ARTICLE Article VI COVENANTS OF THE COMPANY > Section 6.01 Conduct of the Company"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_details",
        "answer": "The dividend structure allows for dividends or other distributions to be paid with respect to shares of Parent Common Stock constituting the Share Consideration. These dividends are payable with a record date on or after the Merger Effective Time and prior to the time of surrender or transfer of shares, and with a payment date subsequent to the time of such surrender or transfer.",
        "summary": "Dividends or distributions are payable on shares of Parent Common Stock with a record date on or after the Merger Effective Time and prior to surrender or transfer, with payment dates after surrender or transfer.",
        "confidence": 0.9,
        "reason": "The clause specifies the timing and conditions under which dividends are payable, implying a structured dividend policy.",
        "clause_text": "Parent shall pay, or cause to be paid, without interest, to the Person in whose name the shares of Parent Common Stock constituting the Share Consideration have been registered... the aggregate amount of all dividends or other distributions payable with respect to such shares of Parent Common Stock with a record date on or after the Merger Effective Time that were paid prior to the time of such surrender or transfer...",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.04 Surrender and Payment > (f)"
      }
    ],
    "parent_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that Parent shall not declare, set aside, or pay any dividend or make any other distribution in respect of any shares of its capital stock, except for regular cash dividends in the ordinary course of business consistent with past practice.",
        "clause_text": "Parent shall not, and shall cause each of its Subsidiaries not to: (c) (ii) declare, set aside or pay any dividend or make any other distribution (whether in cash, stock, property or any combination thereof) in respect of any shares of its capital stock or other Equity Securities, other than (A) in the case of Parent, regular cash dividends in the ordinary course of business consistent with past practice.",
        "reference_section": "ARTICLE Article VII COVENANTS OF PARENT > Section 7.01 Conduct of Parent"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_details",
        "answer": "The Parent is required to pay dividends or other distributions with respect to shares of Parent Common Stock constituting the Share Consideration with a record date on or after the Merger Effective Time and prior to the time of surrender or transfer, and with a payment date subsequent to the time of such surrender or transfer.",
        "summary": "The Parent must pay dividends or distributions on Parent Common Stock issued as Share Consideration if the record date is after the Merger Effective Time and before surrender or transfer, with payment dates after surrender or transfer.",
        "confidence": 0.9,
        "reason": "The clause specifies the conditions under which dividends are payable on the Share Consideration.",
        "clause_text": "Following the surrender of any Certificates, along with the delivery of a properly completed and duly executed letter of transmittal, or the transfer of any Uncertificated Shares, in each case as provided in this Section 2.04, Parent shall pay, or cause to be paid, without interest, to the Person in whose name the shares of Parent Common Stock constituting the Share Consideration have been registered, (i) in connection with the payment of the Share Consideration, (x) the amount of any cash payable in lieu of fractional shares to which such Person is entitled pursuant to Section 2.08, and (y) the aggregate amount of all dividends or other distributions payable with respect to such shares of Parent Common Stock with a record date on or after the Merger Effective Time that were paid prior to the time of such surrender or transfer, and (ii) at the appropriate payment date after the payment of the Merger Consideration, the amount of all dividends or other distributions payable with respect to whole shares of Parent Common Stock constituting the Share Consideration with a record date on or after the Merger Effective Time and prior to the time of such surrender or transfer and with a payment date subsequent to the time of such surrender or transfer.",
        "reference_section": "ARTICLE II – CLOSING; THE MERGER > Section 2.04 Surrender and Payment > (f)"
      }
    ],
    "collar": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not describe any collar provision that adjusts consideration based on stock price movement.",
        "clause_text": "The Merger Consideration and any other amounts payable pursuant to this Agreement shall be appropriately adjusted to eliminate the effect of such event on the Merger Consideration or any such other amounts payable pursuant to this Agreement.",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.07 Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "exchange_ratio": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement defines a specific exchange ratio for the merger consideration.",
        "clause_text": "each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the 'Exchange Ratio') share of Parent Common Stock (the 'Share Consideration')",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_summary",
        "answer": "1",
        "summary": "Each share of Company Common Stock will be converted into the right to receive one share of Parent Common Stock, $50.00 in cash, and one contingent value right.",
        "confidence": 1.0,
        "reason": "The document explicitly states the exchange ratio and consideration components.",
        "clause_text": "each share of Company Common Stock outstanding immediately prior to the Merger Effective Time shall be converted into the right to receive (A) one (the \"Exchange Ratio\") share of Parent Common Stock (the \"Share Consideration\"), subject to Section 2.08 with respect to fractional shares, (B) $50.00 in cash without interest (the \"Cash Consideration\") and (C) one contingent value right (a \"New CVR\") issued by Parent subject to and in accordance with the New CVR Agreement",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.03 Conversion of Shares"
      }
    ],
    "exchange_ratio_adjustment": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement provides for adjustments to the Exchange Ratio based on events such as recapitalizations, stock splits, stock dividends, or other structural changes.",
        "clause_text": "Without limiting or affecting any of the provisions of Section 6.01 or Section 7.01, if, during the period between the date of this Agreement and the Merger Effective Time, any change in the outstanding shares of capital stock of the Company or Parent shall occur as a result of any reclassification, recapitalization, stock split (including reverse stock split), merger, combination, exchange or readjustment of shares, subdivision or other similar transaction, or any stock dividend thereon with a record date during such period, the Merger Consideration and any other amounts payable pursuant to this Agreement shall be appropriately adjusted to eliminate the effect of such event on the Merger Consideration or any such other amounts payable pursuant to this Agreement.",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.07 Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment",
        "answer": "The exchange ratio adjustment mechanism is tied to changes in the outstanding shares of capital stock due to events like reclassification, recapitalization, stock splits, mergers, combinations, exchanges, or similar transactions. The Merger Consideration and any other amounts payable will be adjusted to eliminate the effect of such events.",
        "summary": "The exchange ratio adjustment mechanism accounts for changes in outstanding shares due to specific corporate actions, ensuring the Merger Consideration is adjusted to neutralize the impact of such events.",
        "confidence": 0.9,
        "reason": "The clause specifies adjustments to the Merger Consideration based on changes in outstanding shares due to corporate actions.",
        "clause_text": "Without limiting or affecting any of the provisions of Section 6.01 or Section 7.01, if, during the period between the date of this Agreement and the Merger Effective Time, any change in the outstanding shares of capital stock of the Company or Parent shall occur as a result of any reclassification, recapitalization, stock split (including reverse stock split), merger, combination, exchange or readjustment of shares, subdivision or other similar transaction, or any stock dividend thereon with a record date during such period, the Merger Consideration and any other amounts payable pursuant to this Agreement shall be appropriately adjusted to eliminate the effect of such event on the Merger Consideration or any such other amounts payable pursuant to this Agreement.",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.07 Adjustments"
      }
    ],
    "dividend_adjustment_mechanism": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism_exists",
        "answer": true,
        "summary": "The merger consideration adjusts based on dividends paid pre-closing, as the Merger Consideration shall be appropriately adjusted to eliminate the effect of any stock dividend with a record date during the period between the date of the Agreement and the Merger Effective Time.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Without limiting or affecting any of the provisions of Section 6.01 or Section 7.01, if, during the period between the date of this Agreement and the Merger Effective Time, any change in the outstanding shares of capital stock of the Company or Parent shall occur as a result of any reclassification, recapitalization, stock split (including reverse stock split), merger, combination, exchange or readjustment of shares, subdivision or other similar transaction, or any stock dividend thereon with a record date during such period, the Merger Consideration and any other amounts payable pursuant to this Agreement shall be appropriately adjusted to eliminate the effect of such event on the Merger Consideration or any such other amounts payable pursuant to this Agreement.",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.07 Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism",
        "answer": "The merger consideration will be adjusted to eliminate the effect of any stock dividend or similar transaction on the merger consideration.",
        "summary": "The merger consideration will be adjusted to eliminate the effect of any stock dividend or similar transaction on the merger consideration.",
        "confidence": 0.9,
        "reason": "The clause specifies adjustments to the merger consideration for stock dividends or similar transactions, implying adjustments for dividends.",
        "clause_text": "Without limiting or affecting any of the provisions of Section 6.01 or Section 7.01, if, during the period between the date of this Agreement and the Merger Effective Time, any change in the outstanding shares of capital stock of the Company or Parent shall occur as a result of any reclassification, recapitalization, stock split (including reverse stock split), merger, combination, exchange or readjustment of shares, subdivision or other similar transaction, or any stock dividend thereon with a record date during such period, the Merger Consideration and any other amounts payable pursuant to this Agreement shall be appropriately adjusted to eliminate the effect of such event on the Merger Consideration or any such other amounts payable pursuant to this Agreement.",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.07 Adjustments"
      }
    ]
  },
  "law_and_jurisdiction": {
    "governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that it shall be governed by and construed in accordance with the laws of the State of Delaware.",
        "clause_text": "This Agreement, and all disputes, claims, actions, suits or proceedings based upon, arising out of or related to this Agreement or the transactions contemplated hereby, shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules or principles that would result in the application of the law of any other state.",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.07 Governing Law"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_jurisdiction",
        "answer": "Delaware",
        "summary": "The agreement specifies that it shall be governed by and construed in accordance with the laws of the State of Delaware.",
        "confidence": 1.0,
        "reason": "The governing law jurisdiction is explicitly stated as Delaware.",
        "clause_text": "This Agreement, and all disputes, claims, actions, suits or proceedings based upon, arising out of or related to this Agreement or the transactions contemplated hereby, shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules or principles that would result in the application of the law of any other state.",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.07 Governing Law"
      }
    ],
    "incorporation_details": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "parent_incorporation_details",
        "answer": "a Delaware corporation",
        "summary": "The Parent entity is incorporated as a Delaware corporation, as explicitly stated in the document.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Parent is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware.",
        "reference_section": "ARTICLE Article V REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.01 Corporate Existence and Power"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "company_incorporation_details",
        "answer": "a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware",
        "summary": "The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 4.01 Corporate Existence and Power"
      }
    ],
    "mae_interpretation_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not specify that the interpretation of Material Adverse Effect (MAE) is to be construed under a specific jurisdiction or legal standard.",
        "clause_text": "Company Material Adverse Effect means any event, change, effect, development or occurrence that, individually or together with any other event, change, effect, development or occurrence, has had or would reasonably be expected to have a material adverse effect on the financial condition, business or results of operations of the Company and its Subsidiaries, taken as a whole; provided that no event, change, effect, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Company Material Adverse Effect...",
        "reference_section": "ARTICLE Article I DEFINITIONS > Section 1.01 Definitions > Company Material Adverse Effect"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "financing_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that financing-related disputes involving the Financing Sources are subject to the exclusive jurisdiction of courts in Manhattan, New York.",
        "clause_text": "Notwithstanding anything herein to the contrary, the parties hereto acknowledge and irrevocably agree (i) that any action or proceeding, whether in law or in equity, whether in contract or tort or otherwise, involving the Financing Sources arising out of or related to the transactions contemplated hereby, the Debt Financing or the performance of services thereunder or related thereto shall be subject to the exclusive jurisdiction of any state or federal court sitting in the Borough of Manhattan, New York, New York, and any appellate court thereof...",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.08 Jurisdiction/Venue > (b)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction",
        "answer": "any state or federal court sitting in the Borough of Manhattan, New York, New York",
        "summary": "The jurisdiction for financing-related matters is specified as any state or federal court sitting in the Borough of Manhattan, New York, New York.",
        "confidence": 1.0,
        "reason": "The document explicitly states the jurisdiction for financing-related matters involving the Financing Sources.",
        "clause_text": "Notwithstanding anything herein to the contrary, the parties hereto acknowledge and irrevocably agree (i) that any action or proceeding, whether in law or in equity, whether in contract or tort or otherwise, involving the Financing Sources arising out of or related to the transactions contemplated hereby, the Debt Financing or the performance of services thereunder or related thereto shall be subject to the exclusive jurisdiction of any state or federal court sitting in the Borough of Manhattan, New York, New York, and any appellate court thereof...",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.08 Jurisdiction/Venue > (b)"
      }
    ],
    "arbitration_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies exclusive jurisdiction of courts in Delaware and New York for disputes, with no mention of arbitration.",
        "clause_text": "Each of the parties hereto (i) irrevocably consents to the service of the summons and complaint and any other process with respect to any dispute, claim, action, suit or proceeding based upon, arising out of or related to this Agreement or any of the transactions contemplated hereby... to the exclusive general jurisdiction of the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware...",
        "reference_section": "ARTICLE Article XI MISCELLANEOUS > Section 11.08 Jurisdiction/Venue"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "financing": {
    "committed_financing": [
      {
        "section": "financing",
        "field_name": "committed_financing_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly mentions a fully executed commitment letter for debt financing, indicating committed financing.",
        "clause_text": "Parent has delivered to the Company (i) a true and complete copy of a fully executed commitment letter, dated as of the date hereof, among Parent and the Financing Sources party thereto...",
        "reference_section": "ARTICLE V – REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.27 Financing > (a)"
      },
      {
        "section": "financing",
        "field_name": "committed_financing_summary",
        "answer": "Parent has secured a committed debt financing arrangement through a fully executed commitment letter with Financing Sources, which includes agents, arrangers, and lenders. The Debt Commitment Letter is in full force and effect, and the financing is sufficient to cover all cash payments required at the Closing Date.",
        "summary": "Parent has secured a committed debt financing arrangement through a fully executed commitment letter with Financing Sources, which includes agents, arrangers, and lenders. The Debt Commitment Letter is in full force and effect, and the financing is sufficient to cover all cash payments required at the Closing Date.",
        "confidence": 0.9,
        "reason": "The document specifies the existence of a Debt Commitment Letter with Financing Sources, confirming the committed debt financing arrangement.",
        "clause_text": "Parent has delivered to the Company (i) a true and complete copy of a fully executed commitment letter, dated as of the date hereof, among Parent and the Financing Sources party thereto... The Debt Commitment Letter is in full force and effect and is a legal, valid and binding obligation of Parent...",
        "reference_section": "ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT > Section 5.27 Financing"
      }
    ],
    "financing_efforts_summary": [
      {
        "section": "financing",
        "field_name": "financing_efforts_summary",
        "answer": "Parent and Merger Sub are obligated to use reasonable best efforts to obtain the Debt Financing, maintain the Debt Commitment Letter, and comply with their obligations to ensure the availability of funds for the transaction.",
        "summary": "Parent and Merger Sub are obligated to use reasonable best efforts to obtain the Debt Financing, maintain the Debt Commitment Letter, and comply with their obligations to ensure the availability of funds for the transaction.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the requirement for Parent and Merger Sub to use reasonable best efforts to secure financing and comply with related obligations.",
        "clause_text": "Parent agrees that: (a) Each of Parent and Merger Sub shall, and shall cause their respective Subsidiaries to, use reasonable best efforts to take, or shall use reasonable best efforts to cause to be taken, all actions and to do, or cause to be done, all things necessary to obtain the Debt Financing...",
        "reference_section": "ARTICLE Article VII COVENANTS OF PARENT > Section 7.06 Financing > (a)"
      }
    ],
    "substitute_financing_notice_and_efforts": [
      {
        "section": "financing",
        "field_name": "substitute_financing_notice_and_efforts",
        "answer": "The acquirer is required to notify the company if financing becomes unavailable.",
        "summary": "The acquirer must promptly notify the company if any portion of the Debt Financing becomes unavailable and such portion is necessary to consummate the transactions.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement for the acquirer to notify the company of the unavailability of financing.",
        "clause_text": "In the event that any portion of the Debt Financing becomes unavailable and such portion is necessary to consummate the transactions contemplated by this Agreement... Parent and Merger Sub shall... (ii) promptly notify the Company of such unavailability and the reason therefor.",
        "reference_section": "ARTICLE VII COVENANTS OF PARENT > Section 7.06 Financing > (b)"
      }
    ]
  },
  "proxy_statement": {
    "proxy_statement_filing_timing": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_statement_filing_timing",
        "answer": "As promptly as practicable following the date of this Agreement",
        "summary": "The proxy statement or Form F-4 must be filed with the SEC as promptly as practicable following the date of the Agreement.",
        "confidence": 0.9,
        "reason": "The document specifies that the filing should occur 'as promptly as practicable' after the agreement date.",
        "clause_text": "As promptly as practicable following the date of this Agreement, (i) the Company and Parent shall jointly prepare and file with the SEC a proxy statement relating to the Company Stockholder Meeting and the Parent Stockholder Meeting.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.03 Certain Filings; SEC Matters > (a)"
      }
    ],
    "f4_effectiveness": [
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_efforts",
        "answer": "reasonable best efforts",
        "summary": "The Company and Parent are required to use their reasonable best efforts to have the Joint Proxy Statement/Prospectus cleared by the SEC and the Registration Statement declared effective under the 1933 Act as promptly as practicable.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the use of 'reasonable best efforts' to achieve the effectiveness of the Form F-4.",
        "clause_text": "Each of the Company and Parent shall use its reasonable best efforts to have the Joint Proxy Statement/Prospectus cleared by the SEC as promptly as practicable after its filing, and Parent shall use its reasonable best efforts to have the Registration Statement declared effective under the 1933 Act as promptly as practicable after its filing.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.03 Certain Filings; SEC Matters > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_target_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_timing",
        "answer": "Promptly following the effectiveness of the Registration Statement",
        "summary": "The shareholder meeting is expected to occur promptly following the effectiveness of the Registration Statement.",
        "confidence": 0.9,
        "reason": "The timing for the shareholder meeting is tied to the effectiveness of the Registration Statement.",
        "clause_text": "Promptly following the effectiveness of the Registration Statement (and, in the case of clause (iii), within forty (40) days of the Company Record Date), the Company shall, in consultation with Parent, in accordance with Applicable Law and the Company Organizational Documents, (i) establish a record date (the \"Company Record Date\") for, duly call and give notice of a meeting of the stockholders of the Company entitled to vote on the Merger (the \"Company Stockholder Meeting\") at which meeting the Company shall seek the Company Stockholder Approval...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings > (a)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_deadline",
        "answer": "within forty (40) days of the Company Record Date",
        "summary": "The shareholder meeting must be convened within forty (40) days of the Company Record Date following the effectiveness of the Registration Statement.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline of forty (40) days from the Company Record Date for holding the shareholder meeting.",
        "clause_text": "Promptly following the effectiveness of the Registration Statement (and, in the case of clause (iii), within forty (40) days of the Company Record Date), the Company shall, in consultation with Parent, in accordance with Applicable Law and the Company Organizational Documents, (i) establish a record date (the 'Company Record Date') for, duly call and give notice of a meeting of the stockholders of the Company entitled to vote on the Merger (the 'Company Stockholder Meeting') at which meeting the Company shall seek the Company Stockholder Approval...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings > (a)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_vote_efforts",
        "answer": "reasonable best efforts",
        "summary": "The company is required to use its reasonable best efforts to obtain shareholder approval, including conducting broker searches and soliciting proxies.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that the company shall use its reasonable best efforts to take all actions necessary to obtain shareholder approval.",
        "clause_text": "The Company shall use its reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, necessary, proper or advisable on its part to cause the Company Stockholder Approval to be received at the Company Stockholder Meeting or any adjournment or postponement thereof, and shall comply with all legal requirements applicable to the Company Stockholder Meeting.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings > (a)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_postponment",
        "answer": "The Company may not, without the prior written consent of Parent, postpone the Company Stockholder Meeting more than a total of three (3) times pursuant to clause (A)(1) or (B) of the immediately preceding sentence, and no such postponement or adjournment pursuant to clause (A)(1) or (B) of the immediately preceding sentence shall be, without the prior written consent of Parent, for a period exceeding ten (10) Business Days.",
        "summary": "The Company can postpone the Stockholder Meeting up to three times for specific reasons, with each postponement not exceeding ten business days, without Parent's consent.",
        "confidence": 0.95,
        "reason": "The document explicitly states the limits on the number of postponements and the duration of each postponement.",
        "clause_text": "Notwithstanding the foregoing, the Company may not, without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed), postpone the Company Stockholder Meeting more than a total of three (3) times pursuant to clause (A)(1) or (B) of the immediately preceding sentence, and no such postponement or adjournment pursuant to clause (A)(1) or (B) of the immediately preceding sentence shall be, without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed), for a period exceeding ten (10) Business Days.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings > (a)"
      }
    ],
    "parent_shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_meeting_timing",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_meeting_deadline",
        "answer": "within forty (40) days of the Company Record Date, subject to an extension of up to fifteen (15) additional Business Days",
        "summary": "The Parent must hold its shareholder meeting within forty days of the Company Record Date, with a possible extension of up to fifteen additional business days.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline for the Parent Stockholder Meeting to be held within forty days of the Company Record Date, with a potential extension.",
        "clause_text": "Promptly following the effectiveness of the Registration Statement (and, in the case of clause (iii), within forty (40) days of the Company Record Date, subject to an extension of up to fifteen (15) additional Business Days as contemplated by the last sentence of this Section 8.04(b)), Parent shall, in consultation with the Company, in accordance with Applicable Law and the Parent Organizational Documents, (i) establish a record date (which date shall be the same as the Company Record Date) for, duly call and give notice of a meeting of the stockholders of Parent entitled to vote on the Parent Share Issuance (the \"Parent Stockholder Meeting\") at which meeting Parent shall seek the Parent Stockholder Approval...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_vote_efforts",
        "answer": "use reasonable best efforts",
        "summary": "The Parent is required to use 'reasonable best efforts' to obtain shareholder approval if such approval is required.",
        "confidence": 0.9,
        "reason": "The phrase 'use reasonable best efforts' is explicitly stated in the context of obtaining necessary approvals.",
        "clause_text": "each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as practicable",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.02 Reasonable Best Efforts > (a)"
      },
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_meeting_postponment",
        "answer": "Parent may not, without the prior written consent of the Company, postpone the Parent Stockholder Meeting more than a total of three times, and no such postponement shall be for a period exceeding ten Business Days.",
        "summary": "Parent may adjourn or postpone the Parent Stockholder Meeting up to three times, each for a period not exceeding ten Business Days, without the Company's prior written consent.",
        "confidence": 0.95,
        "reason": "The document explicitly states the limits on the number and duration of postponements for the Parent Stockholder Meeting.",
        "clause_text": "Notwithstanding the foregoing, Parent may not, without the prior written consent of the Company (such consent not to be unreasonably withheld, conditioned or delayed), postpone the Parent Stockholder Meeting more than a total of three (3) times pursuant to clause (A)(1) or (B) of the immediately preceding sentence, and no such postponement or adjournment pursuant to clause (A)(1) or (B) of the immediately preceding sentence shall be, without the prior written consent of the Company (such consent not to be unreasonably withheld, conditioned or delayed), for a period exceeding ten (10) Business Days.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings > (b)"
      }
    ],
    "proxy_summary_notes": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_summary_notes",
        "answer": "The agreement contains notable terms related to proxy or shareholder voting, including flexible timelines for stockholder meetings and conditions under which meetings can be postponed or adjourned.",
        "summary": "The agreement contains notable terms related to proxy or shareholder voting, including flexible timelines for stockholder meetings and conditions under which meetings can be postponed or adjourned.",
        "confidence": 0.9,
        "reason": "The agreement specifies conditions under which stockholder meetings can be postponed or adjourned, indicating flexibility in timelines.",
        "clause_text": "The Company shall not, without the prior written consent of Parent, adjourn, postpone or otherwise delay the Company Stockholder Meeting; provided that the Company may, notwithstanding the foregoing, without the prior written consent of Parent, adjourn or postpone the Company Stockholder Meeting (A) if, after consultation with Parent, the Company believes in good faith that such adjournment or postponement is reasonably necessary to allow reasonable additional time to (1) solicit additional proxies necessary to obtain the Company Stockholder Approval, or (2) distribute any supplement or amendment to the Joint Proxy Statement/Prospectus...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings"
      }
    ],
    "dissenting_shares_cap": [
      {
        "section": "proxy_statement",
        "field_name": "dissenting_shares_cap",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "timeline": {
    "agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "agreement_signing_date",
        "answer": "January 2, 2019",
        "summary": "The merger agreement was officially signed on January 2, 2019, as indicated in the preamble of the document.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of January 2, 2019 is by and among Bristol-Myers Squibb Company, a Delaware corporation (\"Parent\"), Burgundy Merger Sub, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent (\"Merger Sub\"), and Celgene Corporation, a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "confidentiality_agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "confidentiality_agreement_signing_date",
        "answer": "November 23, 2018",
        "summary": "The confidentiality agreement related to the merger was signed on November 23, 2018, as indicated in the document.",
        "confidence": 1.0,
        "reason": "The document explicitly states the date of the confidentiality agreement.",
        "clause_text": "All information furnished pursuant to this Agreement shall be subject to the letter agreement, dated as of November 23, 2018 (as amended, supplemented or otherwise modified from time to time in accordance with its terms, the 'Confidentiality Agreement'), between Parent and the Company.",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.01 Access to Information; Confidentiality > (a)"
      }
    ],
    "announcement_date": [
      {
        "section": "timeline",
        "field_name": "announcement_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "proxy_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "proxy_filing_deadline",
        "answer": "As promptly as practicable",
        "summary": "The preliminary proxy statement and registration statement on Form S-4 must be filed with the SEC as promptly as practicable following the date of the agreement.",
        "confidence": 0.9,
        "reason": "The document specifies that the filing should occur 'as promptly as practicable' after the agreement date.",
        "clause_text": "As promptly as practicable following the date of this Agreement, (i) the Company and Parent shall jointly prepare and file with the SEC a proxy statement relating to the Company Stockholder Meeting and the Parent Stockholder Meeting...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.03 Certain Filings; SEC Matters > (a)"
      }
    ],
    "shareholder_vote_deadline": [
      {
        "section": "timeline",
        "field_name": "shareholder_vote_deadline",
        "answer": "within forty (40) days of the Company Record Date",
        "summary": "The shareholder vote or consent must occur within forty (40) days of the Company Record Date, following the effectiveness of the Registration Statement.",
        "confidence": 0.9,
        "reason": "The document specifies that the Company Stockholder Meeting must be convened within forty (40) days of the Company Record Date.",
        "clause_text": "Promptly following the effectiveness of the Registration Statement (and, in the case of clause (iii), within forty (40) days of the Company Record Date), the Company shall, in consultation with Parent, in accordance with Applicable Law and the Company Organizational Documents, (i) establish a record date (the \"Company Record Date\") for, duly call and give notice of a meeting of the stockholders of the Company entitled to vote on the Merger (the \"Company Stockholder Meeting\") at which meeting the Company shall seek the Company Stockholder Approval...",
        "reference_section": "ARTICLE Article VIII COVENANTS OF PARENT AND THE COMPANY > Section 8.04 Stockholder Meetings > (a)"
      }
    ],
    "outside_date": [
      {
        "section": "timeline",
        "field_name": "outside_date",
        "answer": "January 2, 2020",
        "summary": "The initial 'Outside Date' specified in the agreement is January 2, 2020, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that the merger must be consummated on or before January 2, 2020, which is defined as the 'End Date'.",
        "clause_text": "if: (i) the Merger has not been consummated on or before January 2, 2020 (as such date may be extended pursuant to the following proviso, the 'End Date');",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination > (b) > (i)"
      },
      {
        "section": "timeline",
        "field_name": "outside_date_extension_list",
        "answer": "1. Extension Length: 60 days; Who Grants the Extension: Either Parent or the Company; Conditions to Extend: Conditions to the Closing set forth in Section 9.01(f) or Section 9.01(c) (if related to Section 9.01(f)) not satisfied, but all other conditions satisfied or capable of being satisfied; Termination Restrictions Due to Breach: Yes, the right to extend is not available to any party whose breach is the proximate cause of the failure to consummate the Merger by the End Date. 2. Extension Length: Another 60 days; Who Grants the Extension: Either Parent or the Company; Conditions to Extend: Same conditions as the first extension; Termination Restrictions Due to Breach: Same as the first extension.",
        "summary": "The agreement allows for two potential 60-day extensions of the End Date if specific closing conditions are unmet, provided the party seeking extension is not in breach causing the delay.",
        "confidence": 0.95,
        "reason": "The agreement explicitly outlines conditions and parties responsible for granting extensions, with restrictions on parties in breach.",
        "clause_text": "if on such date, the conditions to the Closing set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to the matters referenced in Section 9.01(f)) shall not have been satisfied, but all other conditions to the Closing shall have been satisfied...then the End Date may be extended by either Parent or the Company for a period of sixty (60) days by written notice to the other party...",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination"
      }
    ],
    "hsr_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "hsr_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "second_request_deadline": [
      {
        "section": "timeline",
        "field_name": "second_request_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "cfius_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "cfius_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "marketing_period_dates": [
      {
        "section": "timeline",
        "field_name": "marketing_period_dates",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "timeline",
        "field_name": "inside_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "closing_date": [
      {
        "section": "timeline",
        "field_name": "closing_date",
        "answer": "third Business Day after the date the conditions set forth in Article IX have been satisfied or waived",
        "summary": "The closing of the Merger shall occur on the third Business Day after the conditions in Article IX are satisfied or waived.",
        "confidence": 0.9,
        "reason": "The document specifies the closing date as the third Business Day after the conditions in Article IX are met or waived.",
        "clause_text": "The closing of the Merger (the \"Closing\") shall take place in New York City at the offices of Kirkland & Ellis LLP, 601 Lexington Avenue, New York, New York, 10022 at 10:00 a.m., Eastern time, on the third (3rd) Business Day after the date the conditions set forth in Article IX (other than conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent permitted by Applicable Law, waiver of such conditions by the party or parties entitled to the benefit thereof at the Closing) have been satisfied or, to the extent permitted by Applicable Law, waived by the party or parties entitled to the benefit thereof, or at such other place, at such other time or on such other date as Parent and the Company may mutually agree (the date on which the Closing occurs, the \"Closing Date\").",
        "reference_section": "ARTICLE Article II CLOSING; THE MERGER > Section 2.01 Closing"
      }
    ],
    "conditions_satisfaction_end_date": [
      {
        "section": "timeline",
        "field_name": "conditions_satisfaction_end_date",
        "answer": "January 2, 2020",
        "summary": "The final date by which all closing conditions must be satisfied under the agreement is January 2, 2020, with possible extensions.",
        "confidence": 0.9,
        "reason": "The agreement specifies January 2, 2020, as the End Date for satisfying conditions, with provisions for extensions.",
        "clause_text": "the Merger has not been consummated on or before January 2, 2020 (as such date may be extended pursuant to the following proviso, the \"End Date\"); provided that, (A) if on such date, the conditions to the Closing set forth in Section 9.01(f) or Section 9.01(c) (if the injunction or other Order relates to the matters referenced in Section 9.01(f)) shall not have been satisfied, but all other conditions to the Closing shall have been satisfied (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on such date) or waived, then the End Date may be extended by either Parent or the Company for a period of sixty (60) days by written notice to the other party",
        "reference_section": "ARTICLE Article X TERMINATION > Section 10.01 Termination"
      }
    ]
  }
}